<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">42179</article-id><article-id pub-id-type="doi">10.7554/eLife.42179</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Highly efficient 5' capping of mitochondrial RNA with NAD<sup>+</sup> and NADH by yeast and human mitochondrial RNA polymerase</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-123255"><name><surname>Bird</surname><given-names>Jeremy G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-123257"><name><surname>Basu</surname><given-names>Urmimala</given-names></name><email>ub19@scarletmail.rutgers.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123258"><name><surname>Kuster</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8157-9223</contrib-id><email>kuster@stud.uni-heidelberg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123259"><name><surname>Ramachandran</surname><given-names>Aparna</given-names></name><email>raparna82@gmail.com</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123260"><name><surname>Grudzien-Nogalska</surname><given-names>Ewa</given-names></name><email>grudzien@dls.rutgers.edu</email><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123261"><name><surname>Towheed</surname><given-names>Atif</given-names></name><email>towheedatif@gmail.com</email><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-7596"><name><surname>Wallace</surname><given-names>Douglas C</given-names></name><email>wallaced1@email.chop.edu</email><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123263"><name><surname>Kiledjian</surname><given-names>Megerditch</given-names></name><email>kiledjian@dls.rutgers.edu</email><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123262"><name><surname>Temiakov</surname><given-names>Dmitry</given-names></name><email>Dmitry.Temiakov@jefferson.edu</email><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-123256"><name><surname>Patel</surname><given-names>Smita S</given-names></name><email>patelss@rwjms.rutgers.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-11021"><name><surname>Ebright</surname><given-names>Richard H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8915-7140</contrib-id><email>ebright@waksman.rutgers.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16312"><name><surname>Nickels</surname><given-names>Bryce E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7449-8831</contrib-id><email>bnickels@waksman.rutgers.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Genetics and Waksman Institute</institution><institution>Rutgers University</institution><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Chemistry and Waksman Institute</institution><institution>Rutgers University</institution><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School</institution><institution>Rutgers University</institution><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Biochemistry PhD Program, School of Graduate Studies</institution><institution>Rutgers University</institution><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Biochemistry Center Heidelberg</institution><institution>Heidelberg University</institution><country>Germany</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Department of Cell Biology and Neuroscience</institution><institution>Rutgers University</institution><country>United States</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Center for Mitochondrial and Epigenomic Medicine</institution><institution>The Children’s Hospital of Philadelphia</institution><country>United States</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">Department of Pediatrics, Division of Human Genetics</institution><institution>The Children's Hospital of Philadelphia, Perelman School of Medicine</institution><country>United States</country></aff><aff id="aff9"><label>9</label><institution content-type="dept">Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center</institution><institution>Thomas Jefferson University</institution><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Hinnebusch</surname><given-names>Alan G</given-names></name><role>Reviewing Editor</role><aff><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Manley</surname><given-names>James L</given-names></name><role>Senior Editor</role><aff><institution>Columbia University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e42179</elocation-id><history><date date-type="received" iso-8601-date="2018-09-19"><day>19</day><month>09</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-12-10"><day>10</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Bird et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Bird et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-42179-v3.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.42179.001</object-id><p>Bacterial and eukaryotic nuclear RNA polymerases (RNAPs) cap RNA with the oxidized and reduced forms of the metabolic effector nicotinamide adenine dinucleotide, NAD<sup>+</sup> and NADH, using NAD<sup>+</sup> and NADH as non-canonical initiating nucleotides for transcription initiation. Here, we show that mitochondrial RNAPs (mtRNAPs) cap RNA with NAD<sup>+</sup> and NADH, and do so more efficiently than nuclear RNAPs. Direct quantitation of NAD<sup>+</sup>- and NADH-capped RNA demonstrates remarkably high levels of capping in vivo: up to ~60% NAD<sup>+</sup> and NADH capping of yeast mitochondrial transcripts, and up to ~15% NAD<sup>+</sup> capping of human mitochondrial transcripts. The capping efficiency is determined by promoter sequence at, and upstream of, the transcription start site and, in yeast and human cells, by intracellular NAD<sup>+</sup> and NADH levels. Our findings indicate mtRNAPs serve as both sensors and actuators in coupling cellular metabolism to mitochondrial transcriptional outputs, sensing NAD<sup>+</sup> and NADH levels and adjusting transcriptional outputs accordingly.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>mitochondria</kwd><kwd>metabolism</kwd><kwd>RNA polymerase</kwd><kwd>transcription initiation</kwd><kwd>non-canonical initiating nucleotide</kwd><kwd>RNA capping</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>16PRE30400001</award-id><principal-award-recipient><name><surname>Basu</surname><given-names>Urmimala</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS021328</award-id><principal-award-recipient><name><surname>Wallace</surname><given-names>Douglas C</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>MH108592</award-id><principal-award-recipient><name><surname>Wallace</surname><given-names>Douglas C</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>OD010944</award-id><principal-award-recipient><name><surname>Wallace</surname><given-names>Douglas C</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>W81XWH-16-1-0401</award-id><principal-award-recipient><name><surname>Wallace</surname><given-names>Douglas C</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM126488</award-id><principal-award-recipient><name><surname>Kiledjian</surname><given-names>Megerditch</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM104231</award-id><principal-award-recipient><name><surname>Temiakov</surname><given-names>Dmitry</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM118086</award-id><principal-award-recipient><name><surname>Patel</surname><given-names>Smita S</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM041376</award-id><principal-award-recipient><name><surname>Ebright</surname><given-names>Richard H</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM118059</award-id><principal-award-recipient><name><surname>Nickels</surname><given-names>Bryce E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Eukaryotic mitochondrial RNA polymerases cap RNA with NAD with much higher efficiencies than nuclear RNA polymerase II; as a consequence, mitochondrial RNAs have remarkably high levels of NAD capping.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Chemical modifications of the RNA 5'-end provide a layer of ‘epitranscriptomic’ regulation, influencing RNA fate, including stability, processing, localization, and translation efficiency (<xref ref-type="bibr" rid="bib31">Höfer and Jäschke, 2018</xref>; <xref ref-type="bibr" rid="bib34">Jäschke et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">Ramanathan et al., 2016</xref>; <xref ref-type="bibr" rid="bib55">Shuman, 2015</xref>). One well-characterized RNA 5'-end modification is the ‘cap’ comprising 7-methylguanylate (m<sup>7</sup>G) added to many eukaryotic messenger RNAs (<xref ref-type="bibr" rid="bib24">Furuichi and Shatkin, 2000</xref>; <xref ref-type="bibr" rid="bib52">Shatkin, 1976</xref>; <xref ref-type="bibr" rid="bib53">Shuman, 1995</xref>; <xref ref-type="bibr" rid="bib66">Wei et al., 1975</xref>). Recently, a new RNA 5'-end cap comprising the metabolic effector nicotinamide adenine dinucleotide (NAD) has been shown to be added to certain RNAs isolated from bacterial, yeast, and human cells (<xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Chen et al., 2009</xref>; <xref ref-type="bibr" rid="bib23">Frindert et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Jiao et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Walters et al., 2017</xref>).</p><p>In contrast to a m<sup>7</sup>G cap, which is added to nascent RNA by a capping complex that associates with eukaryotic RNA polymerase II (RNAP II) (<xref ref-type="bibr" rid="bib25">Ghosh and Lima, 2010</xref>; <xref ref-type="bibr" rid="bib42">Martinez-Rucobo et al., 2015</xref>; <xref ref-type="bibr" rid="bib53">Shuman, 1995</xref>; <xref ref-type="bibr" rid="bib54">Shuman, 2001</xref>; <xref ref-type="bibr" rid="bib55">Shuman, 2015</xref>), an NAD cap is added by RNAP itself during transcription initiation, by serving as a non-canonical initiating nucleotide (NCIN) (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>) (reviewed in <xref ref-type="bibr" rid="bib3">Barvík et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Julius et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Vasilyev et al., 2018</xref>). NCIN-mediated NAD capping has been demonstrated for bacterial RNAP (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Frindert et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Julius and Yuzenkova, 2017</xref>; <xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>) and eukaryotic RNAP II (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>). Thus, whereas m<sup>7</sup>G capping occurs after transcription initiation, on formation of the ~20th phosphodiester bond, and occurs only in organisms harboring specialized capping complexes, NAD capping occurs in transcription initiation, on formation of the first phosphodiester bond, and because it is performed by RNAP itself, is likely to occur in most, if not all, organisms.</p><p>NAD exists in oxidized and reduced forms: NAD<sup>+</sup> and NADH, respectively (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Capping with NAD<sup>+</sup> has been demonstrated both in vitro and in vivo (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Frindert et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Julius and Yuzenkova, 2017</xref>; <xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>). Capping with NADH has been demonstrated in vitro (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Julius and Yuzenkova, 2017</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.42179.002</object-id><label>Figure 1.</label><caption><title><italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+ </sup>and NADH in vitro.</title><p>(<bold>A</bold>) Structures of ATP, NAD<sup>+</sup>, and NADH. Grey, identical atoms; black, distinct atoms. (<bold>B</bold>) Processing of RNA 5' ends by RppH and NudC. A, adenosine; N<sup>+</sup>, NAD<sup>+</sup> nicotinamide; N, NADH nicotinamide; p, phosphate. (<bold>C</bold> and <bold>D</bold>) NCIN capping with NAD<sup>+</sup> and NADH by <italic>S. cerevisiae</italic> mtRNAP (<bold>C</bold>) and human mtRNAP (<bold>D</bold>). Top, promoter derivatives. Middle, initial RNA products of in vitro transcription reactions with ATP, NAD<sup>+</sup>, or NADH as initiating nucleotide and [α<sup>32</sup>P]-GTP as extending nucleotide. Bottom, full-length RNA products of in vitro transcription reactions with ATP, NAD<sup>+</sup>, or NADH as initiating nucleotide and [α<sup>32</sup>P]-GTP, ATP, UTP, and 3'-deoxy-CTP (<bold>C</bold>), or [α<sup>32</sup>P]-GTP, ATP, and UTP (<bold>D</bold>) as extending nucleotides. Products were treated with RppH or NudC as indicated. Grey box and arrow, transcription start site (TSS);+31 and+17/18, position of last NTP incorporated into full-length RNA products; M, 10-nt marker.</p><p><supplementary-material id="fig1sdata1"><object-id pub-id-type="doi">10.7554/eLife.42179.004</object-id><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1C,D</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig1-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><object-id pub-id-type="doi">10.7554/eLife.42179.005</object-id><label>Figure 1—source data 2.</label><caption><title>Data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig1-data2-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42179.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title><italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+</sup> <italic>in vitro</italic>: additional data.</title><p>(<bold>A</bold>) Processing of radiolabeled RNA 5'-ends by alkaline phosphatase (AP) and NudC. A, adenosine; N<sup>+</sup>, NAD<sup>+</sup> nicotinamide; p, phosphate. *, radiolabeled phosphate. (<bold>B</bold> and <bold>C</bold>). NCIN capping with NAD<sup>+</sup> by <italic>S. cerevisiae</italic> mtRNAP (<bold>B</bold>) and human mtRNAP (<bold>C</bold>). Top, promoter derivatives. Bottom, full-length RNA products of in vitro transcription reactions with [γ<sup>32</sup>P]-ATP or [α<sup>32</sup>P]-NAD<sup>+</sup> as initiating nucleotide and GTP, ATP, UTP, and 3'-deoxy-CTP (<bold>C</bold>), or GTP, ATP, and UTP (<bold>D</bold>) as extending nucleotides. Products were treated with NudC alone, AP alone, or NudC and AP, as indicated. Grey box and arrow, TSS; +31 and +17/18, position of last NTP incorporated into RNA; M, 10-nt marker.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig1-figsupp1-v3.tif"/></fig></fig-group><p>Jäschke and co-workers developed a method that combines click-chemistry-mediated covalent capture and high-throughput sequencing, ‘NAD captureSeq,’ to detect NAD<sup>+</sup>-capped RNA (<xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>; <xref ref-type="bibr" rid="bib68">Winz et al., 2017</xref>). Jäschke and co-workers used this method to identify NAD<sup>+</sup>-capped RNAs in bacterial cells (<italic>Escherichia coli</italic> and <italic>Bacillus subtilis</italic>; <xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Frindert et al., 2018</xref>). Parker, Kiledjian, and co-workers used the same method to identify NAD<sup>+</sup>-capped RNAs in eukaryotic cells (<italic>Saccharomyces cerevisiae</italic> and human cell line HEK293T; <xref ref-type="bibr" rid="bib36">Jiao et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Walters et al., 2017</xref>). Notably, the identified <italic>Saccharomyces cerevisiae</italic> NAD<sup>+</sup>-capped RNAs included not only RNAs produced by nuclear RNAPs, but also RNAs produced by mitochondrial RNAP (mtRNAP). The eukaryotic nuclear RNAPs--RNAP I, II, and III--are multi-subunit RNAPs closely related in sequence and structure to bacterial RNAP (<xref ref-type="bibr" rid="bib17">Cramer, 2002</xref>; <xref ref-type="bibr" rid="bib18">Darst, 2001</xref>; <xref ref-type="bibr" rid="bib22">Ebright, 2000</xref>; <xref ref-type="bibr" rid="bib67">Werner and Grohmann, 2011</xref>); in contrast, mtRNAPs are single-subunit RNAPs that are unrelated in sequence and structure to multi-subunit RNAPs and, instead, are related to DNA polymerases, reverse transcriptases, and DNA-dependent RNAPs from T7-like bacteriophages (<xref ref-type="bibr" rid="bib11">Cermakian et al., 1996</xref>; <xref ref-type="bibr" rid="bib13">Cheetham and Steitz, 2000</xref>; <xref ref-type="bibr" rid="bib29">Hillen et al., 2018</xref>; <xref ref-type="bibr" rid="bib43">Masters et al., 1987</xref>; <xref ref-type="bibr" rid="bib44">McAllister and Raskin, 1993</xref>; <xref ref-type="bibr" rid="bib50">Ringel et al., 2011</xref>; <xref ref-type="bibr" rid="bib57">Sousa, 1996</xref>).</p><p>The identification of NAD<sup>+</sup>-capped mitochondrial RNAs in <italic>S. cerevisiae</italic> raises the question of whether eukaryotic single-subunit mtRNAPs--like the structurally unrelated bacterial and eukaryotic nuclear multi-subunit RNAPs--can perform NCIN-mediated capping. A recent review discussed evidence supporting the hypothesis that human mtRNAP can perform NCIN capping (<xref ref-type="bibr" rid="bib38">Julius et al., 2018</xref>). Here, we show that single-subunit <italic>S. cerevisiae</italic> mtRNAP and human mtRNAP perform NCIN-mediated capping with NAD<sup>+</sup> and NADH in vitro, and do so substantially more efficiently than bacterial and eukaryotic multi-subunit RNAPs. Further, we show that capping efficiency is determined by promoter sequence, we demonstrate very high levels of NAD<sup>+</sup> and NADH capping--up to ~60% of mitochondrial transcripts in vivo, and we demonstrate that the extents of capping in vivo, and distributions of NAD<sup>+</sup> capping vs. NADH capping in vivo are influenced by intracellular levels of NAD<sup>+</sup> and NADH.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+</sup> and NADH in vitro</title><p>To assess whether mtRNAP can cap RNA with NAD<sup>+</sup> and NADH, we performed in vitro transcription experiments (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We analyzed <italic>S. cerevisiae</italic> mtRNAP and a DNA template carrying the <italic>S. cerevisiae</italic> mitochondrial 21S promoter (<xref ref-type="bibr" rid="bib21">Deshpande and Patel, 2014</xref>), and, in parallel, human mtRNAP and a DNA template containing a derivative of the human mitochondrial light-strand promoter, LSP<sub>AGU</sub> (<xref ref-type="bibr" rid="bib56">Sologub et al., 2009</xref>) (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>, top). We performed reactions using either ATP, NAD<sup>+</sup>, or NADH as the initiating entity and using [α<sup>32</sup>P]-GTP as the extending nucleotide (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>, middle). We observed efficient formation of an initial RNA product in all cases (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>, middle). The initial RNA products obtained with ATP, but not with NAD<sup>+</sup> or NADH, were processed by RppH, which previous work has shown to process 5'-triphosphate RNAs to 5'-monophosphate RNAs (<xref ref-type="bibr" rid="bib19">Deana et al., 2008</xref>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), whereas the initial RNA products obtained with NAD<sup>+</sup> or NADH, but not with ATP, were processed by NudC, which previous work has shown to process 5'-NAD<sup>+</sup>- and 5'-NADH-capped RNAs to 5'-monophosphate RNAs (<xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Höfer et al., 2016</xref>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The results establish that <italic>S. cerevisiae</italic> mtRNAP and human mtRNAP are able to generate initial RNA products using NAD<sup>+</sup> and NADH as NCINs.</p><p>We next assessed whether the initial RNA products formed using NAD<sup>+</sup> and NADH as NCINs can be extended to yield full-length RNA products (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>, bottom, and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We performed parallel transcription experiments using either ATP, NAD<sup>+</sup>, or NADH as the initiating entity and using [α<sup>32</sup>P]-GTP, ATP, UTP, and 3'-deoxy-CTP (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, bottom) or [α<sup>32</sup>P]-GTP, ATP, and UTP (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, bottom) as extending nucleotides. We observed efficient formation of full-length RNA products in all cases, and we observed that full-length RNA products obtained with NAD<sup>+</sup> or NADH, but not with ATP, were sensitive to NudC treatment (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>, bottom). We also observed efficient formation of full-length RNA products in transcription experiments performed using [α<sup>32</sup>P]-ATP or [<sup>32</sup>P]-NAD<sup>+</sup> as the initiating entity and using non-radiolabeled extending nucleotides (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Full-length products obtained with [<sup>32</sup>P]-NAD<sup>+</sup>, but not with [α<sup>32</sup>P]-ATP, were insensitive to treatment with alkaline phosphatase (which processes 5' phosphates). Furthermore, NudC treatment of full-length products obtained with [<sup>32</sup>P]-NAD<sup>+</sup> yielded products that were sensitive to alkaline phosphatase (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The results establish that <italic>S. cerevisiae</italic> mtRNAP and human mtRNAP not only generate initial RNA products, but also generate full-length RNA products, using NAD<sup>+</sup> and NADH as NCINs.</p></sec><sec id="s2-2"><title><italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+</sup> and NADH more efficiently than bacterial and nuclear RNAPs</title><p>We next determined the relative efficiencies of NCIN-mediated initiation vs. ATP-mediated initiation, (k<sub>cat</sub>/K<sub>M</sub>)<sub>NCIN</sub> / (k<sub>cat</sub>/K<sub>M</sub>)<sub>ATP</sub>, for mtRNAPs (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; methods as in <xref ref-type="bibr" rid="bib6">Bird et al., 2017</xref>). We performed reactions with <italic>S. cerevisiae</italic> mtRNAP and DNA templates carrying the <italic>S. cerevisiae</italic> mitochondrial 21S promoter or 15S promoter (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), and, in parallel, with human mtRNAP and DNA templates carrying the human mitochondrial light-strand promoter (LSP) or heavy-strand promoter (HSP1) (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). We obtained values of (k<sub>cat</sub>/K<sub>M</sub>)<sub>NCIN</sub> / (k<sub>cat</sub>/K<sub>M</sub>)<sub>ATP</sub> of ~0.3 to ~0.4 for NCIN-mediated initiation with NAD<sup>+</sup> and NADH by <italic>S. cerevisiae</italic> mtRNAP and ~0.2 to ~0.6 for NCIN-mediated initiation with NAD<sup>+</sup> and NADH by human mtRNAP. These values imply that NCIN-mediated initiation with NAD<sup>+</sup> or NADH is up to 40% as efficient as initiation with ATP for <italic>S. cerevisiae</italic> mtRNAP and up to 60% as efficient as initiation with ATP for human mtRNAP.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.42179.006</object-id><label>Figure 2.</label><caption><title><italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+ </sup>and NADH more efficiently than bacterial and nuclear RNAPs.</title><p>(<bold>A</bold> and <bold>B</bold>) Dependence of NCIN-mediated capping with NAD<sup>+</sup> and NADH on [NCIN] / [ATP] ratio for <italic>S. cerevisiae</italic> mtRNAP (<bold>A</bold>) and human mtRNAP (<bold>B</bold>) (mean ± SD; n = 3). DNA templates and representative data are shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>. (<bold>C</bold>) Dependence of NCIN-mediated capping with NAD<sup>+</sup> and NADH on [NCIN] / [ATP] ratio for mtRNAPs vs. <italic>E. coli</italic> RNAP and <italic>S. cerevisiae</italic> RNAP II. Top, tailed template. Grey box and arrow indicate TSS. Bottom, dependence of NCIN-mediated capping with NAD<sup>+</sup> and NADH on [NCIN] / [ATP] ratio for <italic>S. cerevisiae</italic> mtRNAP (<italic>Sce</italic> mtRNAP), human mtRNAP, <italic>E. coli</italic> RNAP (<italic>Eco</italic> RNAP) and <italic>S. cerevisiae</italic> RNAP II (<italic>Sce</italic> RNAP II) (mean ± SD; n = 3).</p><p><supplementary-material id="fig2sdata1"><object-id pub-id-type="doi">10.7554/eLife.42179.009</object-id><label>Figure 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig2">Figure 2A,B</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig2-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><object-id pub-id-type="doi">10.7554/eLife.42179.010</object-id><label>Figure 2—source data 2.</label><caption><title>Data for <xref ref-type="fig" rid="fig2">Figure 2C,D</xref>, and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig2-data2-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42179.007</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Dependence of NCIN-mediated capping with NAD<sup>+ </sup>and NADH on [NCIN] / [ATP] ratio for mtRNAPs: representative data.</title><p>(<bold>A</bold> and <bold>B</bold>) Panels show DNA templates and full-length RNA products of in vitro transcription reactions performed with <italic>S. cerevisiae</italic> mtRNAP (<bold>A</bold>) and human mtRNAP (<bold>B</bold>) with the indicated [NCIN] / [ATP] ratio. Grey box and arrow, TSS; +31, +17/18, +15/16, position of last NTP incorporated into RNA; M, 10-nt marker.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig2-figsupp1-v3.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42179.008</object-id><label>Figure 2—figure supplement 2.</label><caption><title><italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+ </sup>and NADH at least as efficiently as bacteriophage T7 RNAP.</title><p>Dependence of NCIN-mediated capping with NAD<sup>+</sup> and NADH on [NCIN] / [ATP] ratio for mtRNAPs vs. T7 RNAP. Top, tailed template. Grey box and arrow indicate TSS. Bottom, Dependence of NCIN-mediated capping with NAD<sup>+</sup> and NADH on [NCIN] / [ATP] ratio for <italic>S. cerevisiae</italic> mtRNAP (<italic>Sce</italic> mtRNAP), human mtRNAP, and T7 RNAP (mean ± SD; n = 3).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig2-figsupp2-v3.tif"/></fig></fig-group><p>The observed efficiencies of NCIN-mediated initiation with NAD<sup>+</sup> or NADH by mtRNAPs are substantially higher than the highest previously reported efficiencies for NCIN-mediated initiation with NAD<sup>+</sup> or NADH by cellular RNAPs (~15%; <xref ref-type="bibr" rid="bib6">Bird et al., 2017</xref>; <xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>). To enable direct comparison of efficiencies of NCIN capping by mtRNAPs vs. cellular RNAPs on the same templates under identical reaction conditions, we performed transcription assays using a ‘tailed’ template (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, top) that bypasses the requirement for sequence-specific RNAP-DNA interactions and transcription-initiation factor-DNA interactions for transcription initiation (<xref ref-type="bibr" rid="bib20">Dedrick and Chamberlin, 1985</xref>; <xref ref-type="bibr" rid="bib40">Kadesch and Chamberlin, 1982</xref>). In these experiments, we observe efficiencies of NCIN-mediated initiation with NAD<sup>+</sup> and NADH by mtRNAP that are fully ~10 to ~40 fold higher than efficiencies of NCIN-mediated initiation with NAD<sup>+</sup> and NADH by <italic>E. coli</italic> RNAP and <italic>S. cerevisiae</italic> RNAP II (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, bottom). We conclude that <italic>S. cerevisiae</italic> mtRNAP and human mtRNAP cap RNA with NAD<sup>+</sup> and NADH more efficiently than bacterial RNAP and eukaryotic nuclear RNAP II.</p><p>We next used the same tailed template and reaction conditions as in assays performed with mtRNAPs to determine the efficiency of NCIN-mediated initiation with NAD<sup>+</sup> and NADH for the single-subunit RNAP of bacteriophage T7 (T7 RNAP) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The efficiencies of NCIN-mediated initiation with NAD<sup>+</sup> and NADH by T7 RNAP were nearly as high as the efficiencies of NCIN-mediated initiation by mtRNAPs. We conclude that there is a quantitative difference in the efficiency of NCIN capping between members of the single-subunit RNAP family (T7 RNAP and mtRNAPs) and members of the multi-subunit RNAP family (bacterial RNAP and eukaryotic nuclear RNAP II).</p></sec><sec id="s2-3"><title>Promoter sequence determines efficiency of RNA capping by mtRNAP</title><p>In previous work, we have shown that NCIN capping with NAD<sup>+</sup> and NADH by bacterial RNAP is determined by promoter sequence, particularly at and immediately upstream of, the transcription start site (TSS) (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>). NCIN capping by bacterial RNAP occurs only at promoters where the base pair (nontemplate-strand base:template-strand base) at the TSS is A:T (+1A promoters), and occurs most efficiently at the subset of +1A promoters where the base pair immediately upstream of the TSS is purine:pyrimidine (−1R promoters). We have further shown that sequence determinants for NCIN capping by bacterial RNAP reside within the template strand of promoter DNA (i.e., the strand that templates incoming nucleotide substrates) (<xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>).</p><p>To determine whether the specificity for A:T at the TSS (position +1), observed with bacterial RNAP, also is observed with mtRNAP, we assessed NAD<sup>+</sup> capping by <italic>S. cerevisiae</italic> mtRNAP using promoter derivatives having A:T or G:C at position +1 (<xref ref-type="fig" rid="fig3">Figure 3A–B</xref>). We observed NAD<sup>+</sup> capping in reactions performed using the promoter derivative having A:T at position +1, but not in reactions performed using the promoter derivative having G:C at position +1 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), indicating specificity for A:T at position +1. To determine whether specificity resides in the template strand for A:T at position +1, we analyzed NAD<sup>+</sup> capping with <italic>S. cerevisiae</italic> mtRNAP using template derivatives having noncomplementary nontemplate- and template-strand-nucleotides (A/C or G/T) at position +1 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We observed NAD<sup>+</sup> capping only with the promoter derivative having T as the template strand base at position +1, indicating that specificity at position +1 resides in the template strand.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.42179.011</object-id><label>Figure 3.</label><caption><title>Promoter sequence determines efficiency of RNA capping with NAD<sup>+</sup> by mtRNAP.</title><p>(<bold>A</bold>) <italic>S. cerevisiae</italic> mitochondrial 21S promoter DNA depicted in the context of the mtRNAP-promoter open complex. DNA nontemplate strand (NT) on top; DNA template strand (T) on bottom; Unwound, non-base-paired DNA region, ‘transcription bubble,’ indicated by raised and lowered nucleotides; +1 and grey boxes, bases at the TSS; −1, bases immediately upstream of the TSS (the 21S promoter is a −1Y promoter). (<bold>B</bold>) Products of transcription reactions with NAD<sup>+</sup> as initiating nucleotide and [α<sup>32</sup>P]-CTP as extending nucleotide for templates having complementary or non-complementary nucleotides at position +1. (<bold>C</bold>) Dependence of NAD<sup>+</sup> capping on [NAD<sup>+</sup>] / [ATP] ratio for homoduplex templates having A:T, G:C, T:A, or C:G at position −1 relative to TSS (mean ± SD; n = 3). Red, −1R promoters; black, −1Y promoters. (<bold>D</bold>) Dependence of NAD<sup>+</sup> capping on [ATP] / [NAD<sup>+</sup>] ratio for heteroduplex templates having an abasic site (*) on the DNA nontemplate strand (mean ± SD; n = 3). Red, promoters with a template-strand Y; black, promoters with a template-strand R. (<bold>E</bold>) Sequence preferences at position −1 for <italic>S. cerevisiae</italic> mtRNAP, <italic>E. coli</italic> RNAP, and T7 RNAP. Graphs show normalized values of (k<sub>cat</sub>/K<sub>M</sub>)<sub>NAD+</sub> / (k<sub>cat</sub>/K<sub>M</sub>)<sub>ATP</sub> determined for homoduplex templates having A:T, G:C, T:A, or C:G at position −1 (mean ± SD; n = 3). Normalized values were calculated by dividing the value for each individual promoter by the average value measured for −1R promoters. Data for <italic>S. cerevisiae</italic> mtRNAP are from panel C, data for <italic>E. coli</italic> RNAP are from (<xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>), and data for T7 RNAP are from <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</p><p><supplementary-material id="fig3sdata1"><object-id pub-id-type="doi">10.7554/eLife.42179.013</object-id><label>Figure 3—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig3-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><object-id pub-id-type="doi">10.7554/eLife.42179.014</object-id><label>Figure 3—source data 2.</label><caption><title>Data for <xref ref-type="fig" rid="fig3">Figure 3C,D,E</xref>, and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig3-data2-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42179.012</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Promoter sequence determines efficiency of RNA capping with NAD<sup>+</sup>: bacteriophage T7 RNAP.</title><p>(<bold>A</bold>) Bacteriophage T7 RNAP-dependent promoter derivatives analyzed. Red, −1R promoters; black, −1Y promoters; +1 and grey box, bases at the TSS; −1, bases immediately upstream of the TSS. (<bold>B</bold>) Dependence of NAD<sup>+</sup> capping on [NAD<sup>+</sup>] / [ATP] ratio for homoduplex templates having A:T, G:C, T:A, or C:G at position −1 relative to TSS (mean ± SD; n = 3).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig3-figsupp1-v3.tif"/></fig></fig-group><p>To determine whether specificity for R:Y at position −1, observed with bacterial RNAP, also is observed with mtRNAP, we analyzed NAD<sup>+</sup> capping by <italic>S. cerevisiae</italic> mtRNAP using promoter derivatives having either R:Y (A:T or G:C) or Y:R (C:G or T:A) at position −1 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). We observed higher efficiencies of NAD<sup>+</sup> capping with promoter derivatives having R:Y at position −1 than with promoter derivatives having Y:R (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). To determine whether specificity at position −1 resides in the DNA template strand, we performed experiments using promoter derivatives having Y (C or T) or R (A or G) at position −1 of the template strand and having an abasic site (*) on the nontemplate strand (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). We observed higher efficiencies of NAD<sup>+</sup> capping in reactions performed using promoter derivatives having Y at template-strand position −1 than with those having R. Furthermore, within error, the capping efficiencies for promoter derivatives having Y or R at template-strand position −1 matched the capping efficiencies for homoduplex promoter derivatives (<xref ref-type="fig" rid="fig3">Figure 3C–D</xref>), indicating that sequence information for NAD<sup>+</sup> capping with <italic>S. cerevisiae</italic> mtRNAP resides exclusively in the template strand.</p><p>We conclude that NCIN capping with NAD<sup>+</sup> by mtRNAP is determined by the sequence at, and immediately upstream of, the TSS (positions +1 and −1, respectively). We further conclude that the sequence and strand preferences at positions +1 and −1 for NCIN capping with NAD<sup>+</sup> by mtRNAP match the sequence and strand preferences observed for bacterial RNAP (<xref ref-type="fig" rid="fig3">Figure 3C–E</xref>) (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>), suggesting that these sequence and strand preferences may be universal determinants of NCIN capping with NAD<sup>+</sup> for all RNAPs. Consistent with this hypothesis, we find that sequence preferences for NCIN capping with NAD<sup>+</sup> by bacteriophage T7 RNAP, another member of the single-subunit RNAP family, match the sequence preferences observed for <italic>S. cerevisiae</italic> mtRNAP and bacterial RNAP (<xref ref-type="fig" rid="fig3">Figure 3E</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Further consistent with this hypothesis, structural modeling suggests the basis for these sequence and strand preferences is universal: specifically, a strict requirement for template-strand +1T for base pairing to the NAD<sup>+</sup> adenine moiety, and a preference for template strand −1Y for ‘pseudo’ base pairing to the NAD<sup>+</sup> nicotinamide moiety (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>).</p></sec><sec id="s2-4"><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: boronate affinity electrophoresis with processed RNA and synthetic standards</title><p>Kössel, Jäschke and co-workers have demonstrated that boronate affinity electrophoresis allows resolution of uncapped RNAs from capped RNAs--such as m<sup>7</sup>G, NAD<sup>+</sup> and NADH--that contain a vicinal-diol moiety (<xref ref-type="bibr" rid="bib32">Igloi and Kössel, 1985</xref>; <xref ref-type="bibr" rid="bib33">Igloi and Kössel, 1987</xref>; <xref ref-type="bibr" rid="bib45">Nübel et al., 2017</xref>). However, the procedures of Kössel, Jäschke and co-workers have two limitations: (i) boronate affinity electrophoresis does not allow resolution of RNAs longer than ~200 nt, and (ii) boronate affinity electrophoresis, by itself, is unable to distinguish between different vicinal-diol containing cap structures (m<sup>7</sup>G, NAD<sup>+</sup>, NADH, or others). Here, to overcome these limitations, we have combined boronate affinity electrophoresis with use of oligodeoxynucleotide-mediated RNA cleavage (‘DNAzyme’ cleavage) (<xref ref-type="bibr" rid="bib37">Joyce, 2001</xref>) and use of synthetic NCIN-capped RNA standards generated using NCIN-mediated transcription initiation in vitro (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Use of DNAzyme cleavage enables processing of long RNAs to yield defined, short, 5'-end-containing subfragments (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Use of synthetic NCIN-capped RNA standards enables distinction between capped species (<xref ref-type="fig" rid="fig4">Figure 4A,D</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.42179.015</object-id><label>Figure 4.</label><caption><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: boronate affinity electrophoresis with DNAzyme-cleaved cellular RNA and DNAzyme-cleaved synthetic NCIN-capped RNA standards.</title><p>(<bold>A</bold>) Use of DNAzyme (DZ) to process RNA to yield a defined, short 5'-end-containing subfragment, in parallel in vivo (red) and in vitro (blue). Uncapped, 5'-triphosphate (ppp) end generated using ATP-mediated initiation; 5'-NAD<sup>+</sup>, NAD<sup>+</sup>-capped end generated using NAD<sup>+</sup>-mediated initiation; 5'-NADH, NADH-capped end generated using NADH-mediated initiation. (<bold>B</bold>) Use of boronate affinity electrophoresis to resolve 5'-uncapped, 5'-NAD<sup>+</sup>, and 5'-NADH containing RNAs. Grey, structure of phenylboronic acid (PB) polyacrylamide gel. (<bold>C</bold>) PB-polyacrylamide gel (left) and polyacrylamide gel (right) analysis of DNAzyme-generated 5'-end-containing subfragments of <italic>S. cerevisiae</italic> mitochondrial RNA COX2. Red, observed 5'-end-containing RNA subfragments resolved by PB-polyacylamide-gel (left) or not resolved by polyacrylamide gel (right); identities of these subfragments are defined in Panel D. (<bold>D</bold>) Comparison of electrophoretic mobilities of observed 5'-end-containing subfragments of COX2 RNA generated in vivo to 5'-end-containing subfragments of synthetic RNA standards generated in vitro. a, NAD<sup>+</sup>-capped RNA; b, NADH-capped RNA; c, uncapped RNA (mean ± SD; n = 3).</p><p><supplementary-material id="fig4sdata1"><object-id pub-id-type="doi">10.7554/eLife.42179.016</object-id><label>Figure 4—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig4-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig4-v3.tif"/></fig><p>To detect and quantify NCIN capping with NAD<sup>+</sup> and NADH in mitochondrial RNA isolated from cells, we employed the following steps: (i) DNAzyme cleavage of target RNAs to generate 5'-end-containing subfragments &lt; 80 nt in length (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, top); (ii) DNAzyme treatment of synthetic NAD<sup>+</sup>- and NADH-capped RNA standards having sequences identical to RNAs of interest (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, bottom); (iii) boronate affinity electrophoresis of DNAzyme-generated subfragments of mitochondrial RNA and DNAzyme-generated subfragments of synthetic NAD<sup>+</sup>- and NADH-capped RNA standards having sequences identical to RNAs of interest (<xref ref-type="fig" rid="fig4">Figure 4B</xref>); and (iv) detection of DNAzyme-generated 5'-end-containing subfragments of mitochondrial RNAs and synthetic RNA standards by hybridization with a radiolabeled oligodeoxyribonucleotide probe (<xref ref-type="fig" rid="fig4">Figure 4C–D</xref>).</p><p>We selected for analysis two <italic>S. cerevisiae</italic> mitochondrial RNAs that previously had been detected as NAD<sup>+</sup>-capped: COX2 and 21S (<xref ref-type="bibr" rid="bib65">Walters et al., 2017</xref>). We isolated <italic>S. cerevisiae</italic> total RNA and analyzed COX2 and 21S RNAs using the procedure described in the preceding paragraph. The results are presented in <xref ref-type="fig" rid="fig4">Figures 4C–D</xref> and <xref ref-type="fig" rid="fig5">5A</xref> (top). For both COX2 and 21S RNAs, we detect at least one RNA species with electrophoretic mobility retarded as compared to that of uncapped RNA, indicating the presence of capped RNA. Treatment with the decapping enzyme NudC eliminates these species, confirming the presence of capping. Comparison of the electrophoretic mobilities to those of synthetic NAD<sup>+</sup>- and NADH-capped RNA standards indicates that one of the capped species is NAD<sup>+</sup>-capped RNA, and the other capped species, present under these growth conditions only for COX2 RNA, is NADH-capped RNA. The results show that both COX2 and 21S RNAs are present in NAD<sup>+</sup>-capped forms, and that COX2 RNA also is present in an NADH-capped-form. Because the hybridization probe detects RNA fragments that contain 5' ends generated by transcription initiation (red subfragment depicted in <xref ref-type="fig" rid="fig4">Figure 4A</xref>), the detected NAD<sup>+</sup> and NADH caps are concluded to be at 5' ends generated by transcription initiation, as opposed to 5' ends generated by RNA processing. The results confirm that <italic>S. cerevisiae</italic> mitochondrial RNAs undergo NAD<sup>+</sup> capping in cells, show that <italic>S. cerevisiae</italic> mitochondrial RNAs undergo NAD<sup>+</sup> capping at 5' ends generated by transcription initiation (as opposed to 5' ends generated by RNA processing), and show that <italic>S. cerevisiae</italic> mitochondrial RNAs also undergo NADH capping in cells.</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.42179.017</object-id><label>Figure 5.</label><caption><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: effects of intracellular NAD<sup>+ </sup>and NADH levels in <italic>S. cerevisiae</italic> and human cells.</title><p>(<bold>A</bold>) Changes in intracellular NAD<sup>+</sup>/NADH ratios result in changes in levels of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA (mean ± SD; n = 3). Gel images show representative data for <italic>S. cerevisiae</italic> COX2 RNA (left) and 21S RNA (right). Blue annotations as in <xref ref-type="fig" rid="fig4">Figure 4</xref>. (<bold>B</bold>) Changes in intracellular NAD(H) levels result in changes in levels of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA (mean ± SD; n = 3). Gel images show representative data for LSP-derived RNAs. Red, NAD(H) biosynthesis inhibitor FK866; NAMPT, Nicotinamide phosphoribosyltransferase; NMNAT, Nicotinamide mononucleotide adenylyltransferase.</p><p><supplementary-material id="fig5sdata1"><object-id pub-id-type="doi">10.7554/eLife.42179.018</object-id><label>Figure 5—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig5">Figure 5</xref> (gels).</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig5-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><object-id pub-id-type="doi">10.7554/eLife.42179.019</object-id><label>Figure 5—source data 2.</label><caption><title>Data for <xref ref-type="fig" rid="fig5">Figure 5</xref> (values of NCIN capping).</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42179-fig5-data2-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42179-fig5-v3.tif"/></fig><p>The observed levels of NAD<sup>+</sup>- and NADH-capping of <italic>S. cerevisiae</italic> mitochondrial RNAs are remarkably high. For COX2 RNA, NAD<sup>+</sup>-capped RNA comprises ~50% of the total COX2 RNA pool and NADH-capped RNA comprises ~10% of the total COX2 RNA pool (<xref ref-type="fig" rid="fig4">Figures 4C–D</xref> and <xref ref-type="fig" rid="fig5">5A</xref>, top). For 21S RNA, NAD<sup>+</sup>-capped RNA comprises ~30% of the total 21S RNA pool (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, top). These levels of NCIN capping are ~2 to ~50 times higher than levels of NCIN-capping in exponentially growing <italic>E. coli</italic> (less than 1% to ~20% for NAD<sup>+</sup>-capping; not previously detected for NADH-capping) (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>; <xref ref-type="bibr" rid="bib45">Nübel et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Vvedenskaya et al., 2018</xref>).</p><p>We performed analogous experiments analyzing RNAs produced by transcription from the human mitochondrial LSP promoter (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, top). We isolated and analyzed total RNA from HEK293T cells. We observed an NAD<sup>+</sup>-capped species comprising ~15% of the total LSP-derived RNA pool (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, top). The results establish that human mitochondrial RNAs undergo NAD<sup>+</sup> capping in cells and show that human mitochondrial RNAs undergo NAD<sup>+</sup> capping at 5' ends generated by transcription initiation (as opposed to 5' ends generated by RNA processing).</p></sec><sec id="s2-5"><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: mtRNAPs serve as both sensors and actuators in coupling cellular metabolism to mitochondrial gene expression</title><p>Mitochondria are the primary locus of metabolism and energy transformation in the eukaryotic cell, serving as the venue for the tricarboxylic acid cycle (TCA) cycle and oxidative phosphorylation. The TCA cycle reduces NAD<sup>+</sup> to NADH and oxidative phosphorylation oxidizes NADH to NAD<sup>+</sup>. Our finding that mtRNAPs perform NCIN capping with NAD<sup>+</sup> and NADH at efficiencies that vary in a simple mass-action-dependent fashion with [NAD<sup>+</sup>] / [ATP] and [NADH] / [ATP] ratios in vitro (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref>), and our finding that mtRNAPs perform efficient NCIN capping to yield NAD<sup>+</sup>- and NADH-capped mitochondrial RNAs in vivo (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>), raise the possibility that mtRNAPs may serve as both sensors and actuators in coupling metabolism to mitochondrial gene expression in vivo.</p><p>As a first test of this hypothesis, we assessed whether changing intracellular [NAD<sup>+</sup>] / [NADH] ratios results in changes in NAD<sup>+</sup> and NADH capping of mitochondrial RNAs. We isolated total RNA from <italic>S. cerevisiae</italic> grown under conditions that result in either high or low [NAD<sup>+</sup>] / [NADH] ratios (<xref ref-type="bibr" rid="bib4">Bekers et al., 2015</xref>; <xref ref-type="bibr" rid="bib10">Canelas et al., 2008</xref>): respiration (glycerol/ethanol; aerobic) or fermentation (glucose; anaerobic). We analyzed the same two mitochondrial RNAs as above: COX2 and 21S (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We observed marked changes in levels of NAD<sup>+</sup> and NADH capping for both analyzed mitochondrial RNAs. For COX2 RNA, on changing from the growth condition yielding a high [NAD<sup>+</sup>] / [NADH] ratio to the growth condition yielding a low [NAD<sup>+</sup>] / [NADH] ratio, we observe a decrease in levels of NAD<sup>+</sup> capping (from ~50% to ~20%) and an anti-correlated increase in the level of NADH capping (from ~10% to ~40%). Notably, the total level of NAD<sup>+</sup> and NADH capping, NAD(H) capping, remains constant under the two conditions (~60%), indicating that the relative levels of NCIN-mediated initiation and ATP-mediated initiation do not change (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). For 21S RNA, the same pattern is observed (<xref ref-type="fig" rid="fig5">Figure 5A</xref>): on changing from the growth condition yielding a high [NAD<sup>+</sup>] / [NADH] ratio to the growth condition yielding a low [NAD<sup>+</sup>] / [NADH] ratio, the level of NAD<sup>+</sup> capping decreases (from ~30% to ~10%), the level of NADH capping increases (from 0% to ~20%), and the total level of NAD<sup>+</sup> and NADH capping remains constant (~30%). The results indicate that changing the [NAD<sup>+</sup>] / [NADH] ratio changes transcription outputs in vivo.</p><p>As a second test of this hypothesis, we assessed whether changing intracellular total NAD(H) levels results in changes in NCIN capping of mitochondrial RNAs (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). We isolated RNA from human HEK293T cells grown under conditions yielding either high or low intracellular NAD(H) levels: standard growth media or growth media in the presence of the NAD(H)-biosynthesis inhibitor FK866 (<xref ref-type="bibr" rid="bib28">Hasmann and Schemainda, 2003</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2006</xref>). We analyzed the same LSP-derived mitochondrial RNA as in the preceding section (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). On changing from the growth condition yielding high intracellular NAD(H) levels to the growth condition yielding low NAD(H) levels, we observe a marked change in the total level of NCIN capping (from ~15% to 0%). The results indicate that changing NAD(H) levels changes levels of NCIN-capped mitochondrial RNAs in vivo.</p><p>Taken together, the results of the two experiments in <xref ref-type="fig" rid="fig5">Figure 5</xref> indicate that mtRNAP serves as both sensor and actuator in coupling [NAD<sup>+</sup>] / [NADH] ratios to relative levels of NAD<sup>+</sup>- and NADH-capped mitochondrial RNAs (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), and in coupling total NAD(H) levels to total levels of NCIN-capped mitochondrial RNAs (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), thereby coupling cellular metabolism to mitochondrial transcription outputs. We suggest that mtRNAPs serve as sensors through their mass-action-dependence in selecting NAD<sup>+</sup> vs. NADH vs. ATP as the initiating entity during transcription initiation, and serve as actuators by incorporating NAD<sup>+</sup> vs. NADH vs. ATP at the RNA 5' end during transcription initiation.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our results show that <italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+</sup> and NADH (<xref ref-type="fig" rid="fig1">Figure 1</xref>), show that <italic>S. cerevisiae</italic> and human mtRNAPs cap RNA with NAD<sup>+</sup> and NADH more efficiently than bacterial and eukaryotic nuclear RNAPs (<xref ref-type="fig" rid="fig2">Figure 2</xref>), and show that capping efficiency by mtRNAPs is determined by promoter sequence (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Our results further show that the proportions of mitochondrial RNAs that are capped with NAD<sup>+</sup> and NADH are remarkably high--up to ~60% (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>)--and that these proportions change in response to cellular NAD<sup>+</sup> and NADH levels (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><p>We and others previously have shown that NCIN capping by cellular RNAPs has functional consequences, including modulating RNA stability and modulating RNA translatability (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>; <xref ref-type="bibr" rid="bib36">Jiao et al., 2017</xref>). Our results here showing that <italic>S. cerevisiae</italic> and human mitochondrial RNAs are capped at substantially higher levels than non-mitochondrial RNAs--up to ~60% for analyzed <italic>S. cerevisiae</italic> mitochondrial RNAs and up to ~15% for analyzed human mitochondrial RNAs (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>)--suggest that NCIN capping in mitochondria occurs at a higher efficiency, and has a higher importance, than NCIN capping in other cellular compartments. Four other considerations support this hypothesis. First, mtRNAPs are substantially more efficient at NAD<sup>+</sup> and NADH capping than bacterial and eukaryotic nuclear RNAPs (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Second, levels of NAD<sup>+</sup> and NADH relative to ATP in mitochondria are substantially higher than levels of NAD<sup>+</sup> and NADH relative to ATP in bacteria and eukaryotic nuclei (<xref ref-type="bibr" rid="bib9">Cambronne et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Park et al., 2016</xref>). Third, all <italic>S. cerevisiae</italic> and human mitochondrial promoters are +1A promoters (18 promoters in <italic>S. cerevisiae</italic> mitochondria; two promoters in human mitochondria) (<xref ref-type="bibr" rid="bib7">Biswas, 1999</xref>; <xref ref-type="bibr" rid="bib12">Chang and Clayton, 1984</xref>; <xref ref-type="bibr" rid="bib58">Taanman, 1999</xref>), in contrast to bacterial and eukaryotic nuclear RNAP promoters, for which approximately half are +1A promoters (<xref ref-type="bibr" rid="bib15">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="bib27">Haberle et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Saito et al., 2013</xref>; <xref ref-type="bibr" rid="bib61">Thomason et al., 2015</xref>; <xref ref-type="bibr" rid="bib62">Tsuchihara et al., 2009</xref>). Fourth, we observe capping with both NAD<sup>+</sup> and NADH for mitochondrial RNAs in vivo (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>), whereas, to date, capping has been observed with only NAD<sup>+</sup> for non-mitochondrial RNAs in vivo, raising the possibility that, in mitochondria, but not in other cellular compartments, NAD<sup>+</sup> and NADH caps dictate different RNA fates and, correspondingly, different transcription outputs.</p><p>Our results showing that levels of NAD<sup>+</sup> and NADH capping by mtRNAP correlate with changes in intracellular levels of NAD<sup>+</sup> and NADH (<xref ref-type="fig" rid="fig5">Figure 5</xref>) indicate that mtRNAP serves as a sensor, sensing [NAD<sup>+</sup>] / [ATP] and [NADH] / [ATP] ratios, when selecting initiating entities and, simultaneously, serves as an actuator by altering RNA 5' ends when selecting initiating entities. Because all <italic>S. cerevisiae</italic> and human mitochondrial promoters are +1A promoters, this dual sensor/actuator activity of mtRNAP will occur at, and couple metabolism to gene expression at, all <italic>S. cerevisiae</italic> and human mitochondrial promoters. This dual sensor/actuator activity of mtRNAP obviates the need for a dedicated signal-processing machinery for coupling metabolism to gene expression, instead employing a pan-eukaryotic housekeeping enzyme for signal processing. As such, this dual sensor/actuator activity of mtRNAP provides a remarkably economical, parsimonious mechanism of coupling metabolism to gene expression.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Strain, strain <break/>background <break/>(<italic>E. coli</italic>)</td><td>BL21(DE3) bacteria</td><td>NEB</td><td>C2527H</td><td/></tr><tr><td>Strain, strain <break/>background <break/>(<italic>E. coli</italic>)</td><td>NiCo21(DE3) bacteria</td><td>NEB</td><td>C2529H</td><td/></tr><tr><td>Strain, strain <break/>background <break/>(<italic>E. coli</italic>)</td><td>Artic Express (DE3) <break/>bacteria</td><td>Fisher Scientific</td><td>NC9444283</td><td/></tr><tr><td>Strain, strain <break/>background <break/>(<italic>S. cerevisiae</italic>)</td><td>246.1.1 <break/>(<italic>MATa ura3 trp1 leu2 his4</italic>)</td><td>Gift of A. Vershon</td><td/><td/></tr><tr><td>Cell line <break/>(human)</td><td>HEK293T <break/>(human embryonic <break/>kidney cells)</td><td>ATCC</td><td>CRL-3216</td><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pIA900</td><td>Gift of I. <break/>Artsimovitch</td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pET NudC-His</td><td>(<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>)</td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pJJ1399</td><td>gift of J. Jaehning</td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pTrcHisC-Mtf1</td><td>gift of J. Jaehning</td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pPROEXHTb-POLRMT <break/>(43–1230)−6xHis</td><td>(<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>)</td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pPROEXHTb-TFAM <break/>(43-245)−6xHis</td><td>(<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>)</td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pT7TEV-HMBP4</td><td>(<xref ref-type="bibr" rid="bib69">Yakubovskaya et al., 2014</xref>)</td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pAR1219</td><td>(<xref ref-type="bibr" rid="bib35">Jia et al., 1996</xref>)</td><td/><td/></tr><tr><td>Sequence-based <break/>reagent</td><td>DK64</td><td>Integrated DNA <break/>Technologies (IDT)</td><td>tailed template with <break/>PEG<sub>6</sub> linker</td><td>GGCTCGCCTCGGCTCG/iSp18/ <break/>CGAGCCGAGGCGAGCGTCACCAA</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB459</td><td>IDT</td><td>human LSP DNA template <break/> + 1 AGU variant nontemplate <break/>strand</td><td>GTGTTAGTTGGGGGGTGACTGTT <break/>AAAAGTGCATACCGCCAAAGTATA <break/>AAATTTGTGGGCC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB460</td><td>IDT</td><td>human LSP DNA template <break/>+ 1 AGU variant template <break/>strand</td><td>GGCCCACAAATTTTATACTTTGGC <break/>GGTATGCACTTTTAACAGTCACCC <break/>CCCAACTAACAC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB469</td><td>IDT</td><td>T7φ2.5–35 n nontemplate <break/>strand (−1T)</td><td>CAGTAATACGACTCACTATTAGCGAA <break/>GCGGGCATGCGGCCAGCCATAGC <break/>CGATCA</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB470</td><td>IDT</td><td>T7φ2.5–35 n template <break/>strand (−1A)</td><td>TGATCGGCTATGGCTGGCCGCATGCC <break/>CGCTTCGCTAATAGTGAGTCGTA <break/>TTACTG</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB471</td><td>IDT</td><td>T7φ2.5–35 n nontemplate <break/>strand (−1A)</td><td>CAGTAATACGACTCACTATAAGCGAAGC <break/>GGGCATGCGGCCAGCCATAG <break/>CCGATCA</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB472</td><td>IDT</td><td>T7φ2.5–35 n template <break/>strand (−1T)</td><td>TGATCGGCTATGGCTGGCCGCATGCCC <break/>GCTTCGCTTATAGTGAGTCGTATTACTG</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB473</td><td>IDT</td><td>T7φ2.5–35 n nontemplate <break/>strand (−1G)</td><td>CAGTAATACGACTCACTATGAGCGAAG <break/>CGGGCATGCGGCCAGCCATAG <break/>CCGATCA</td></tr><tr><td>Sequence based <break/>reagent</td><td>JB474</td><td>IDT</td><td>T7φ2.5 35 n template <break/>strand (−1C)</td><td>TGATCGGCTATGGCTGGCCGCATGCC <break/>CGCTTCGCTCATAGTGAGTCGTATTACTG</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB475</td><td>IDT</td><td>T7φ2.5–35 n nontemplate <break/>strand (−1C)</td><td>CAGTAATACGACTCACTATCAGCGAA <break/>GCGGGCATGCGGCCAGCCA <break/>TAGCCGATCA</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB476</td><td>IDT</td><td>T7φ2.5–35 n template <break/>strand (−1G)</td><td>TGATCGGCTATGGCTGGCCGCATGC <break/>CCGCTTCGCTGATAGTG <break/>AGTCGTATTACTG</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB515</td><td>IDT</td><td>probe for human LSP-generated <break/>RNA (complementary to <break/>positions + 2 to+31)</td><td>CACCAGCCTAACCAGATTTCAA <break/>ATTTTATC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB525</td><td>IDT</td><td>probe for <italic>S. cerevisiae</italic> <break/>21S RNA (complementary <break/>to positions + 9 to+42)</td><td>CTATATAATAAATATTTCAAATC <break/>TATTATTCTAC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB526</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S RNA <break/>DNAzyme; cleaves transcript <break/>at position + 53</td><td>ACTCCATGATTAGGCTAGCTACAA <break/>CGACTCTTTAAATCT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB555</td><td>IDT</td><td>probe for <italic>S. cerevisiae</italic> <break/>COX2 RNA (complementary <break/>to positions + 8 to+46)</td><td>ATCTTAACCTTTAGACTCTTTTGTC <break/>TATTTATAATATGT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB557</td><td>IDT</td><td><italic>S. cerevisiae</italic> COX2 DNAzyme; <break/>cleaves at position + 57</td><td>TCTTAATAAATCTAAGGCTAGCTACA <break/>ACGAATTTTAATAAATCTT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB559</td><td>IDT</td><td>human LSP-generated RNA <break/>DNAzyme; cleaves at <break/>position + 67</td><td>GCACTTAAACAGGCTAGCTACAA <break/>CGAATCTCTGCCA</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB560</td><td>IDT</td><td><italic>S. cerevisiae</italic> COX2 −40 <break/>to + 125 nontemplate strand <break/>oligo (for generation of <break/>in vitro transcription template)</td><td>TATATAATAATAAATTATAAATAAATTTT <break/>AATTAAAAGTAGTATTAACATATTATAAA <break/>TAGACAAAAGAGTCTAAAGGTTAAGATT <break/>TATTAAAATGTTAGATTTATTAAGATTAC <break/>AATTAACAAC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB561</td><td>IDT</td><td><italic>S. cerevisiae</italic> COX2 −40 to + 3 <break/>forward primer (for generation <break/>of in vitro transcription template)</td><td>TATATAATAATAAATTATAAATAAATTTT <break/>AATTAAAAGTAGT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB562</td><td>IDT</td><td><italic>S. cerevisiae</italic> COX2 + 83 to+125 <break/>reverse primer (for generation <break/>of in vitro transcription template)</td><td>GTTGTTAATTGTAATCTTAATAAATCTAA <break/>CATTTTAATAAATC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB1</td><td>IDT</td><td>human LSP DNA template (−43 <break/>to + 19) nontemplate strand</td><td>ATGTGTTAGTTGGGGGGTGACTGTTAA <break/>AAGTGCATACCGCCAAAAGATAAAATT <break/>TGAAATCTG</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB2</td><td>IDT</td><td>human LSP DNA template <break/>(−43 to + 19) template <break/>strand</td><td>CAGATTTCAAATTTTATCTTTTGGCGGT <break/>ATGCACTTTTAACAGTCACCCCCCAAC <break/>TAACACAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB3</td><td>IDT</td><td>human HSP1 DNA template <break/>(−43 to + 20) nontemplate <break/>strand</td><td>ACACACCGCTGCTAACCCCATACCCCGA <break/>ACCAACCAAACCCCAAAGACACCCGCC <break/>ACAGTTTA</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB4</td><td>IDT</td><td>human HSP1 DNA template <break/>(−43 to + 20) template <break/>strand</td><td>TAAACTGTGGCGGGTGTCTTTGGGGT <break/>TTGGTTGGTTCGGGGTATGGGGTTA <break/>GCAGCGGTGTGT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB5</td><td>IDT</td><td><italic>S. cerevisiae</italic> 15S DNA <break/>template (−25 to + 1; <break/>C-less cassette) nontemplate <break/>strand</td><td>ATAATTTATTTATTATTATATAAGTAAT <break/>AAATAATTGTTTTATATAATAAGAA <break/>TTCTCCTTC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB6</td><td>IDT</td><td><italic>S. cerevisiae</italic> 15S DNA template <break/>(−25 to + 1; C-less cassette) <break/>template strand</td><td>GAAGGAGAATTCTTATTATATAAAACA <break/>ATTATTTATTACTTATATAATAATAA <break/>ATAAATTAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB7</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S DNA <break/>template (−25 to + 1; <break/>C-less cassette) nontemplate <break/>strand</td><td>TATTATTATTATTATATATATAAGTAG <break/>TAAAAAGTAGAATAATAGATTT <break/>GAAATACC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB8</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S DNA <break/>template (−25 to + 1; <break/>C-less cassette) template <break/>strand</td><td>GAAGGAGACCAACCACAAACACACA <break/>ACAACCACCAACTACTTATATAATAA <break/>TAAATAAATTAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB9</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S DNA <break/>template (−25 to + 1; C-less <break/>and A-less cassette) nontemplate <break/>strand</td><td>ATAATTTATTTATTATTATATAAGTAG <break/>TTGGTGGTTGTTGTGTGTTTGTG <break/>GTTGGTCTCCTTC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB10</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S DNA <break/>template (−25to + 1; <break/>C-less and A-less cassette) <break/>template strand</td><td>GAAGGAGACCAACCACAAACACAC <break/>AACAACCACCAACTACTTATATAA <break/>TAATAAATAAATTAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB11</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>nontemplate strand <break/>(−1A)</td><td>ATAATTTATTTATTATTATATAAGAA <break/>GTTGGTGGTTGTTGTGTGTTTGTG <break/>GTTGGTCTCCTTC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB12</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S template <break/>strand (−1T)</td><td>GAAGGAGACCAACCACAAACACA <break/>CAACAACCACCAACTTCTTATATA <break/>ATAATAAATAAATTAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB13</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>nontemplate strand <break/>(−1G)</td><td>ATAATTTATTTATTATTATATAAGG <break/>AGTTGGTGGTTGTTGTGTGTTTG <break/>TGGTTGGTCTCCTTC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB14</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>template strand <break/>(−1C)</td><td>GAAGGAGACCAACCACAAACACA <break/>CAACAACCACCAACTCCTTATAT <break/>AATAATAAATAAATTAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB15</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>nontemplate strand <break/>(−1C)</td><td>ATAATTTATTTATTATTATATAAG <break/>CAGTTGGTGGTTGTTGTGTGT <break/>TTGTGGTTGGTCTCCTTC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB16</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>template strand <break/>(−1G)</td><td>GAAGGAGACCAACCACAAACACA <break/>CAACAACCACCAACTGCTTATATA <break/>ATAATAAATAAATTAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB17</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>nontemplate strand <break/>(+1C)</td><td>ATAATTTATTTATTATTATATAAGTC <break/>GTTGGTGGTTGTTGTGTGTTTGT <break/>GGTTGGTCTCCTTC</td></tr><tr><td>Sequence-based <break/>reagent</td><td>UB18</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>template strand <break/>(+1G)</td><td>GAAGGAGACCAACCACAAACACAC <break/>AACAACCACCAACGACTTATATAA <break/>TAATAAATAAATTAT</td></tr><tr><td>Sequence-based <break/>reagent</td><td>JB527</td><td>IDT</td><td><italic>S. cerevisiae</italic> 21S <break/>nontemplate strand <break/>(−1 abasic)</td><td>ATAATTTATTTATTATTATATAAG/ <break/>idSp/AGTTGGTGGTTGTTGTGTGT <break/>TTGTGGTTGGTCTCCTTC</td></tr><tr><td>Peptide, recombinant <break/>protein (<italic>S. cerevisiae</italic>)</td><td>Rpo41 (mtRNAP)</td><td>(<xref ref-type="bibr" rid="bib59">Tang et al., 2009</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein (<italic>S. cerevisiae</italic>)</td><td>Mtf1</td><td>(<xref ref-type="bibr" rid="bib46">Paratkar and Patel, 2010</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein (Human)</td><td>POLRMT (mtRNAP)</td><td>(<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein (Human)</td><td>TFAM</td><td>(<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein (Human)</td><td>TFB2</td><td>(<xref ref-type="bibr" rid="bib69">Yakubovskaya et al., 2014</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein (<italic>S. cerevisiae</italic>)</td><td>RNA <break/>polymerase II</td><td>Gift of C. Kaplan</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein (<italic>E. coli</italic>)</td><td>RNA polymerase <break/>core (β'−6xHis)</td><td>(<xref ref-type="bibr" rid="bib1">Artsimovitch et al., 2003</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein</td><td>T7 RNA polymerase</td><td>(<xref ref-type="bibr" rid="bib35">Jia et al., 1996</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein (<italic>E. coli</italic>)</td><td>NudC</td><td>(<xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>)</td><td/><td/></tr><tr><td>Peptide, recombinant <break/>protein</td><td>Phusion Flash HF <break/>master mix</td><td>ThermoFisher</td><td>F-548L</td><td/></tr><tr><td>Peptide, recombinant <break/>protein</td><td>T4 Polynucleotide <break/>Kinase</td><td>NEB</td><td>M0201L</td><td/></tr><tr><td>Peptide, recombinant <break/>protein</td><td>RNA 5' <break/>pyrophosphohydrolase <break/>(RppH)</td><td>NEB</td><td>M0356S</td><td/></tr><tr><td>Peptide, recombinant <break/>protein</td><td>FastAP Alkaline <break/>Phosphatase</td><td>Thermo Fisher</td><td>EF0651</td><td/></tr><tr><td>Commercial assay <break/>or kit</td><td>Monarch PCR and DNA <break/>clean up kit</td><td>NEB</td><td>T1030S</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Nuclease-free water <break/>(not DEPC-treated)</td><td>ThermoFisher</td><td>AM9932</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Bacto agar</td><td>VWR</td><td>90000–760</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Bacto tryptone</td><td>VWR</td><td>90000–286</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Bacto yeast extract</td><td>VWR</td><td>90000–726</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>D-Glucose <break/>monhydrate</td><td>Amresco</td><td>0643–1 kg</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Glycerol</td><td>EMD Millipore</td><td>55069521</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>DMEM medium</td><td>Thermo Fisher</td><td>11965–092</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Fetal Bovine Serum</td><td>Atlanta Biological</td><td>S11150H</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>dNTP solution mix, <break/>10 mM of each NTP</td><td>NEB</td><td>N0447S</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>NTP set (ultra-pure), <break/>100 mM solutions</td><td>GE Healthcare</td><td>27-2025-01</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>NAD<sup>+</sup></td><td>Roche <break/>(Sigma-Aldrich)</td><td>10127965001</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>NADH</td><td>Roche <break/>(Sigma-Aldrich)</td><td>10107735001</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Tris base (Amresco)</td><td>VWR</td><td>97061–800</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Boric Acid (ACS grade)</td><td>VWR</td><td>97061–980</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>EDTA disodium salt <break/>dyhydrate</td><td>VWR</td><td>97061–018</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>0.5 M EDTA pH 8</td><td>ThermoFisher</td><td>AM9260G</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Dibasic Sodium <break/>phosphate</td><td>EMD Millipore</td><td>SX0715-1</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Sodium Chloride</td><td>EMD Millipore</td><td>SX0420-3</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Potassium Chloride</td><td>EMD Millipore</td><td>7300–500 GM</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Sodium Citrate</td><td>EMD Millipore</td><td>7810–1 KG</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Sodium Acetate, <break/>trihydrate</td><td>VWR</td><td>MK736406</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Ficoll 400</td><td>VWR</td><td>AAB22095-18</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Polyvinylpyrrolidone</td><td>EMD Millipore</td><td>7220–1 KG</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Diethyl Pyrocarbonate <break/>(DEPC)</td><td>VWR</td><td>AAB22753-14</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Formamide, <break/>deionized</td><td>VWR</td><td>EM-4610</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Sodium <break/>dodecylsulfate (SDS)</td><td>VWR</td><td>97064–470</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Magnesium chloride <break/>hexahydrate</td><td>VWR</td><td>EM-5980</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Magnesium sulfate <break/>heptahydrate</td><td>VWR</td><td>EM-MX0070-1</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Glycerol (ACS grade)</td><td>VWR</td><td>EMGX0185-5</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Bovine Serum Albumin <break/>(BSA) fraction V</td><td>VWR</td><td>101174–932</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Bromophenol Blue</td><td>VWR</td><td>EM-BX1410-7</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Xylene Cyanol</td><td>Sigma-Aldrich</td><td>X4126-10G</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Amaranth Dye</td><td>VWR</td><td>200030–400</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Temed (JT Baker)</td><td>VWR</td><td>JT4098-1</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Ammonium Persulfate</td><td>VWR</td><td>97064–594</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Dithiothreitol (DTT)</td><td>Gold Bio</td><td>DTT50</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Glycogen from Oyster <break/>(type II)</td><td>Sigma-Aldrich</td><td>G8751</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Hydrochloric Acid <break/>(ACS plus)</td><td>Fisher Scientific</td><td>A144-212</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Ethyl Alcohol</td><td>Pharmco-AAPER</td><td>111000200</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>GeneMate LE Quick <break/>Dissolve agarose</td><td>BioExpress</td><td>E-3119–500</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>SequaGel sequencing <break/>system</td><td>National <break/>Diagnostics</td><td>EC833</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Nytran SuPerCharge <break/>Nylon Membrane</td><td>VWR</td><td>10416296</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>SigmaSpin G25 cleanup <break/>columns</td><td>Sigma-Aldrich</td><td>S5059</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td><sup>32</sup>P NAD<sup>+</sup> 250 uCi</td><td>Perkin Elmer</td><td>BLU023X250UC</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>γ-<sup>32</sup>P ATP Easy <break/>Tide 1 mCi</td><td>Perkin Elmer</td><td>BLU502Z001MC</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>α-<sup>32</sup>P CTP Easy <break/>Tide 250 uCi</td><td>Perkin Elmer</td><td>BLU508H250UC</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>α-<sup>32</sup>P GTP Easy <break/>Tide 250 uCi</td><td>Perkin Elmer</td><td>BLU506H250UC</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>α-<sup>32</sup>P UTP Easy <break/>Tide 250 uCi</td><td>Perkin Elmer</td><td>BLU507H250UC</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Decade Marker</td><td>Thermo Fisher</td><td>AM7778</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>TRI Reagent</td><td>Molecular <break/>Research Center</td><td>TR118</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>Acid phenol:chloroform <break/>(CHCl<sub>3</sub>) pH 4.5</td><td>ThermoFisher</td><td>AM9720</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>FK866 hydrochloride <break/>hyrate</td><td>Sigma-Aldrich</td><td>F8557</td><td/></tr><tr><td>Software, algorithm</td><td>Excel</td><td>Microsoft</td><td>365</td><td/></tr><tr><td>Software, algorithm</td><td>ImageQuant</td><td>GE Healthcare</td><td>TL 5.1, TL v8.2</td><td/></tr><tr><td>Software, algorithm</td><td>SigmaPlot</td><td>Systat Software Inc.</td><td>Version 10</td><td/></tr><tr><td>Software, algorithm</td><td>Pymol</td><td>Schrodinger, LLC</td><td><ext-link ext-link-type="uri" xlink:href="http://www.pymol.org">http://www.pymol.org</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Illustrator</td><td>Adobe</td><td>Version CS6</td><td/></tr><tr><td>Other</td><td>Typhoon RBG Imager</td><td>GE Healthcare</td><td/><td/></tr><tr><td>Other</td><td>NanoDrop 2000C <break/>spectrophotometer</td><td>Thermo Fisher</td><td/><td/></tr><tr><td>Other</td><td>UV Crosslinker</td><td>Fisher Scientific</td><td>FB-UVXL-1000</td><td/></tr><tr><td>Other</td><td>Hybridization oven 5420</td><td>VWR</td><td>97005–252</td><td/></tr><tr><td>Other</td><td>Sequi-Gen GT sequencing <break/>systems (21 × 50) (38 × 30)</td><td>Bio-Rad</td><td>1653871 and 1653873</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Proteins</title><p><italic>S. cerevisiae</italic> mtRNAP (Rpo41) was prepared from <italic>E. coli</italic> strain BL21(DE3) transformed with pJJ1399 (gift of Judith A. Jaehning) using culture and induction procedures, polyethyleneimine treatment, ammonium sulfate precipitation, Ni-sepharose, DEAE sepharose and Heparin-sepharose chromatography as in (<xref ref-type="bibr" rid="bib59">Tang et al., 2009</xref>). <italic>S. cerevisiae</italic> Mtf1 was prepared from <italic>E. coli</italic> strain BL21(DE3) transformed with pTrcHisC-Mtf1 (<xref ref-type="bibr" rid="bib46">Paratkar and Patel, 2010</xref>) and purified using culture and induction procedures, polyethyleneimine treatment, ammonium sulfate precipitation, and tandem DEAE sepharose and Ni-sepharose chromatography as in (<xref ref-type="bibr" rid="bib59">Tang et al., 2009</xref>).</p><p>Human mtRNAP (POLRMT) and TFAM were purified from <italic>E. coli</italic> strain BL21(DE3) transformed with pPROEXHTb-POLRMT(43–1230)−6xHis (<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>) or pPROEXHTb-TFAM(43-245)−6xHis (<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>), respectively, using culture and induction procedures, polyethyleneimine treatment, ammonium sulfate precipitation, and Ni-sepharose and heparin-sepharose chromatography as in (<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>). Human TFB2 was purified from <italic>E. coli</italic> strain ArcticExpress (DE3) (Stratagene) transformed with pT7TEV-HMBP4 (<xref ref-type="bibr" rid="bib69">Yakubovskaya et al., 2014</xref>), using culture and induction procedures, polyethyleneimine treatment, ammonium sulfate precipitation, Ni-sepharose and heparin-sepharose chromatography, and size exclusion chromatography as in (<xref ref-type="bibr" rid="bib69">Yakubovskaya et al., 2014</xref>).</p><p>T7 RNAP was prepared from <italic>E. coli</italic> strain BL21 transformed with pAR1219 using culture and inductions procedures, SP-Sephadex, CM-Sephadex and DEAE-Sephacel chromatography as described in (<xref ref-type="bibr" rid="bib35">Jia et al., 1996</xref>).</p><p><italic>E. coli</italic> RNAP core enzyme was prepared from <italic>E. coli</italic> strain NiCo21(DE3) transformed with plasmid pIA900 (<xref ref-type="bibr" rid="bib1">Artsimovitch et al., 2003</xref>) using culture and induction procedures, immobilized-metal-ion affinity chromatography on Ni-NTA agarose, and affinity chromatography on Heparin HP as in (<xref ref-type="bibr" rid="bib1">Artsimovitch et al., 2003</xref>).</p><p><italic>S. cerevisiae</italic> RNA polymerase II core enzyme (gift of Craig Kaplan) was prepared as described in (<xref ref-type="bibr" rid="bib2">Barnes et al., 2015</xref>).</p><p><italic>E. coli</italic> NudC was prepared from <italic>E. coli</italic> strain NiCo21(DE3) transformed with plasmid pET NudC-His (<xref ref-type="bibr" rid="bib5">Bird et al., 2016</xref>) using metal-ion chromatography and size-exclusion chromatography as in (<xref ref-type="bibr" rid="bib8">Cahová et al., 2015</xref>).</p><p>RNA 5' pyrophosphohydrolase (RppH) and T4 polynucleotide kinase (PNK) were purchased from New England Biolabs (NEB). FastAP Thermosensitive Alkaline Phosphatase was purchased from Thermo Fisher Scientific. Molar concentrations of purified proteins were determined by light absorbance at 280 nm and the calculated respective molar extinction coefficients.</p></sec><sec id="s4-2"><title>Oligodeoxyribonucleotides</title><p>Sequences of the oligodeoxyribonucleotides used in this work are provided in Key Resources Table. All oligodeoxyribonucleotides were purchased from Integrated DNA Technologies (IDT) with standard desalting purification unless otherwise specified.</p><p>Linear in vitro transcription templates used for transcription assays shown in <xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig3">3</xref> were generated by mixing complementary equimolar amounts of nontemplate- and template-strand DNA in 10 mM Tris HCl pH 8.0, incubating the mixture at 95°C for 5 min, and cooling the mixture by 0.5°C per minute to 25°C.</p><p>Transcription templates used to generate in vitro RNA standards for Northern analysis (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>) were generated by PCR. Reactions contained a mixture of 5 nM template oligo, 0.5 µM forward primer, 0.5 µM reverse primer, and Phusion HF Master Mix (Thermo Scientific). Reaction products were isolated using a Monarch PCR and DNA cleanup kit (NEB).</p><p>The radiolabeled 10-nt marker labeled ‘M’ in gel images shown in <xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig4">4</xref> and <xref ref-type="fig" rid="fig5">5</xref> was generated using the Decade Marker System (Thermo Fisher Scientific), PNK (NEB) and [γ<sup>32</sup>P]-ATP (Perkin Elmer; 6,000 Ci/mmol).</p></sec><sec id="s4-3"><title>In vitro transcription assays</title><p>Assays performed with <italic>S. cerevisiae</italic> mtRNAP were based on procedures described in (<xref ref-type="bibr" rid="bib21">Deshpande and Patel, 2014</xref>). Assays performed with human mtRNAP were based on procedures described in (<xref ref-type="bibr" rid="bib48">Ramachandran et al., 2017</xref>).</p><p>For initial RNA product assays in <xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, and <xref ref-type="fig" rid="fig3">Figure 3</xref>, 1 µM DNA template, 1 µM <italic>S. cerevisiae</italic> mtRNAP, and 1 µM Mtf1 were incubated at 25°C for 10 min in <italic>Sce</italic>-mtRNAP reaction buffer (50 mM Tris-acetate pH 7.5, 100 mM potassium glutamate, 10 mM magnesium acetate, 0.01% Tween-20, 1 mM DTT, and 5% glycerol). A mixture containing the initiating nucleotide (200 µM ATP, 1 mM NAD<sup>+</sup>, or 1 mM NADH) and extending nucleotide (10 µM of non-radiolabeled GTP plus 6 mCi of [α<sup>32</sup>P]-GTP [Perkin Elmer; 3,000 Ci/mmol]) was added, and assays were incubated at 25°C for 30 min. For assays in <xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> and radiolabeled initial products were isolated using a Nanosep 3 kDa cutoff spin concentrator (Pall). For assays in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, reactions were stopped with 10 µl RNA loading dye (95% deionized formamide, 18 mM EDTA, 0.25% SDS, xylene cyanol, bromophenol blue, amaranth) and were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National Diagnostics), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).</p><p>For the initial RNA product assays in <xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, 1 µM DNA template, 1 µM human mtRNAP, 1 µM TFAM, and 1 µM TFB2M were incubated at 25°C for 10 min in human-mtRNAP reaction buffer (50 mM Tris-acetate pH 7.5, 50 mM sodium glutamate, 10 mM magnesium acetate, 1 mM DTT, and 0.05% Tween-20). A mixture containing the initiating nucleotide (200 µM ATP, 1 mM NAD<sup>+</sup>, or 1 mM NADH) and extending nucleotide (10 µM of non-radiolabeled GTP plus 6 mCi of [α<sup>32</sup>P]-GTP at [Perkin Elmer; 3,000 Ci/mmol]) was added, and assays were incubated at 25°C for 60 min. Radiolabeled initial RNA products were isolated using a Nanosep 3 kDa cutoff spin concentrator (Pall).</p><p>A portion of the recovered initial RNA products were mixed with either 10 U of RppH or 400 nM NudC and incubated at 37°C for 30 min. Reactions were stopped by addition of 10 µl RNA loading dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National Diagnostics), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).</p><p>For full-length product assays in <xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> (panel B), 1 µM DNA template, 1 µM <italic>S. cerevisiae</italic> mtRNAP, and 1 µM Mtf1 were incubated at 25°C for 10 min in <italic>Sce</italic>-mtRNAP reaction buffer. A mixture containing the initiating nucleotide (1 mM ATP, 1 mM NAD<sup>+</sup>, or 1 mM NADH for <xref ref-type="fig" rid="fig1">Figure 1C</xref>; 200 µM non-radiolabeled ATP plus 10 µCi [γ<sup>32</sup>P]-ATP [Perkin Elmer; 6,000 Ci/mmol] or 1 mM NAD<sup>+</sup> plus 20 µCi [α<sup>32</sup>P]-NAD<sup>+</sup> [Perkin Elmer; 800 Ci/mmol] for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) and extending nucleotides (200 µM GTP, 200 µM 3'-deoxy-CTP, 20 µM ATP, 200 µM non-radiolabeled UTP, and 6 mCi of [α<sup>32</sup>P]-UTP [Perkin Elmer; 3000 Ci/mmol] for <xref ref-type="fig" rid="fig1">Figure 1C</xref>; 200 µM GTP, 200 µM 3'-deoxy-CTP, 20 µM ATP, 200 µM UTP for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) was added, and assays were incubated at 25°C for 30 min. Reactions were stopped by addition of stop solution (0.6 M Tris HCl pH 8.0, 18 mM EDTA, 0.1 mg/ml glycogen), samples were extracted with acid phenol:chloroform (5:1, pH 4.5; Thermo Fisher Scientific), and RNA products were recovered by ethanol precipitation and resuspended in NudC reaction buffer (10 mM Tris HCl pH 8.0, 50 mM NaCl, 10 mM MgCl<sub>2</sub>, 1 mM DTT).</p><p>For full-length product assays in <xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> (panel C), 1 µM DNA template, 1 µM human mtRNAP, 1 µM TFAM, and 1 µM TFB2M were incubated at 25°C for 10 min in human-mtRNAP reaction buffer. A mixture containing the initiating nucleotide (1 mM ATP, 1 mM NAD<sup>+</sup>, or 1 mM NADH for <xref ref-type="fig" rid="fig1">Figure 1D</xref>; 200 µM non-radiolabeled ATP plus 10 µCi [γ<sup>32</sup>P]-ATP [Perkin Elmer; 6000 Ci/mmol] or 1 mM NAD<sup>+</sup> plus 20 µCi [α<sup>32</sup>P]-NAD<sup>+</sup> [Perkin Elmer; 800 Ci/mmol] for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) and extending nucleotides (200 µM GTP, 20 µM ATP, 200 µM non-radiolabeled UTP, and 6 mCi of [α<sup>32</sup>P]-UTP [Perkin Elmer; 3000 Ci/mmol] for <xref ref-type="fig" rid="fig1">Figure 1D</xref>; 200 µM GTP, 20 µM ATP, 200 µM UTP for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) was added, and assays were incubated at 25°C for 60 min. Reactions were stopped by addition of stop solution, samples were extracted with acid phenol:chloroform (5:1) (pH 4.5; Thermo Fisher Scientific), RNA products were recovered by ethanol precipitation and resuspended in NudC reaction buffer.</p><p>Full-length RNA products were incubated at 37°C for 30 min with 400 nM NudC alone (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), 0.25 U FastAP Thermosensitive Alkaline Phosphatase alone (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), or both NudC and FastAP (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Reactions were stopped by addition of an equal volume of RNA loading dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National Diagnostics), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).</p></sec><sec id="s4-4"><title>Determination of efficiency of NCIN-mediated initiation vs. ATP-mediated initiation, (k<sub>cat</sub>/K<sub>M</sub>)<sub>NCIN</sub> / (k<sub>cat</sub>/K<sub>M</sub>)<sub>ATP,</sub>in vitro: full-length product assays</title><p>For experiments in <xref ref-type="fig" rid="fig2">Figure 2A–B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, 1 µM of template DNA, 1 µM of mtRNAP, and 1 µM transcription factor(s) (Mtf1 for <italic>S. cerevisiae</italic> mtRNAP; TFAM and TFB2M for human mtRNAP) were incubated at 25°C for 10 min in <italic>Sce</italic>-mtRNAP or human reaction buffer. A mixture containing 200 µM ATP, 200 µM UTP, 200 µM non-radiolabeled GTP, and 6 mCi [α<sup>32</sup>P]-GTP at 3000 Ci/mmol and NCIN (0, 50, 100, 200, 400, 800, 1600, 3200, 6400 µM) was added, and assays were incubated at 25°C for 30 min. Reactions were stopped by addition of an equal volume of RNA loading dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National Diagnostics) supplemented with 0.2% 3-acrylamidophenylboronic acid (Boron Molecular), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).</p><p>Bands corresponding to uncapped (pppRNA) and NCIN-capped (NCIN-RNA) full-length products were quantified using ImageQuant software. The ratio of NCIN-RNA to total RNA [NCIN-RNA / (pppRNA + NCIN RNA)] was plotted vs. the relative concentrations of NCIN vs. ATP ([NCIN] / [ATP]) on a semi-log plot (SigmaPlot) and non-linear regression was used to fit the data to the equation: y = (ax) / (b + x); where y is [NCIN-RNA / (pppRNA + NCIN RNA)], x is ([NCIN] / [ATP]), and a and b are regression parameters. The resulting fit yields the value of x for which y = 0.5. The relative efficiency (k<sub>cat</sub>/K<sub>M</sub>)<sub>NCIN</sub> / (k<sub>cat</sub>/K<sub>M</sub>)<sub>ATP</sub> is equal to 1/x. Data for determination of relative efficiencies are means of three technical replicates.</p></sec><sec id="s4-5"><title>Determination of efficiency of NCIN-mediated initiation vs. ATP-mediated initiation, (k<sub>cat</sub>/K<sub>M</sub>)<sub>NCIN</sub> / (k<sub>cat</sub>/K<sub>M</sub>)<sub>ATP,</sub>in vitro: initial product assays (<xref ref-type="bibr" rid="bib6">Bird et al., 2017</xref>)</title><p>For experiments in <xref ref-type="fig" rid="fig3">Figure 3C–D</xref>, and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, 1 µM of template DNA, 1 µM of RNAP, and 1 µM transcription factor(s) (Mtf1 for <italic>S. cerevisiae</italic> mtRNAP; TFAM and TFB2M for human mtRNAP; none for T7 RNAP) were incubated at 25°C for 10 min in <italic>Sce</italic>-mtRNAP, human mtRNAP reaction buffer, or T7 RNAP reaction buffer (40 mM Tris HCl pH 7.9, 6 mM MgCl<sub>2</sub>, 2 mM DTT, 2 mM Spermidine). A mixture containing 1 mM NCIN, ATP (0, 25, 50, 100, 200, 400, 800, 1600 µM), 20 µM non-radiolabeled GTP, and 6 mCi [α<sup>32</sup>P]-GTP at 3000 Ci/mmol was added, and assays were incubated at 25°C for 30 min. Reactions were stopped by addition of an equal volume of RNA loading dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National Diagnostics) supplemented with 0.2% 3-acrylamidophenylboronic acid (Boron Molecular), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).</p><p>For experiments in <xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplements 2</xref>, 200 nM of tailed template and 500 nM RNAP (<italic>S. cerevisiae</italic> mtRNAP, human mtRNAP, <italic>S. cerevisiae</italic> RNAP II, T7 RNAP, or <italic>E. coli</italic> RNAP) were incubated at 25°C for 15 min in reaction buffer containing 10 mM Tris pH 8.0, 50 mM potassium glutamate, 10 mM MgCl<sub>2</sub>, 2 mM DTT, and 50 ug/ml BSA. A mixture containing NCIN (1 mM NCIN for mtRNAPs, T7 RNAP, and <italic>E. coli</italic> RNAP; 4 mM for <italic>S. cerevisiae</italic> RNAP II), ATP (0, 25, 50, 100, 200, 400, 800, 1600 µM for mtRNAPs and <italic>S. cerevisiae</italic> RNAP II; 0, 6.25, 12.5, 25, 50, 100, 200, 400 µM for <italic>E. coli</italic> RNAP), 10 µM non-radiolabeled CTP, and 6 mCi [α<sup>32</sup>P]-CTP (Perkin Elmer; 3000 Ci/mmol) was added, and assays were incubated at 25°C for 1 hr. Reactions were stopped by addition of an equal volume of RNA loading dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National Diagnostics), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).</p><p>Bands corresponding to uncapped (pppApC) and NCIN-capped (NCINpC) initial RNA products were quantified using ImageQuant software. The ratio of NCINpC to total RNA (NCINpC / [pppApC + NCINpC]) was plotted vs. the relative concentrations of NCIN vs. ATP ([NCIN] / [ATP]) on a semi-log plot (SigmaPlot) and non-linear regression was used to fit the data to the equation: y = (ax) / (b + x); where y is [NCINpC / (pppApC + NCINpC)], x is ([NCIN] / [ATP]), and a and b are regression parameters. The resulting fit yields the value of x for which y = 0.5. The relative efficiency (k<sub>cat</sub>/K<sub>M</sub>)<sub>NCIN</sub> / (k<sub>cat</sub>/K<sub>M</sub>)<sub>ATP</sub> is equal to 1/x. Data for determination of relative efficiencies are means of three technical replicates.</p></sec><sec id="s4-6"><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: isolation of total cellular RNA from <italic>S. cerevisiae</italic></title><p>For analysis of NAD<sup>+</sup> and NADH capping during respiration, <italic>S. cerevisiae</italic> strain 246.1.1 [(<xref ref-type="bibr" rid="bib60">Tatchell et al., 1981</xref>); <italic>MAT</italic>α <italic>ura3 trp1 leu2 his4</italic>; gift of Andrew Vershon, Rutgers University] was grown at 30°C in 25 ml YPEG (24 g Bacto-tryptone, 20 g Bacto-yeast extract, 30 mL ethanol, 3% glycerol per liter) in 125 ml flasks (Bellco) shaken at 220 rpm. When cell density reached an OD600 ~1.8 (approximately 24 hr) the cell suspension was centrifuged to collect cells (5 min, 10,000 g at 4°C), supernatants were removed, and cell pellets were resuspended in 0.8 mL RNA extraction buffer (0.5 mM NaOAc pH 5.5, 10 mM EDTA, 0.5% SDS).</p><p>For analysis of NAD<sup>+</sup> and NADH capping during fermentation, <italic>S. cerevisiae</italic> strain 246.1.1 was grown at 30°C in 100 ml YPD [24 g Bacto-tryptone, 20 g Bacto-yeast extract, 2% (w/v) glucose per liter] in 125 ml flasks (Bellco) with airlocks to prevent oxygenation without shaking for 42 hr. The cell suspension was centrifuged to collect cells (5 min, 10,000 g at 4°C), supernatants were removed, and cell pellets were resuspended in 0.8 mL RNA extraction buffer (0.5 mM NaOAc pH 5.5, 10 mM EDTA, 0.5% SDS).</p><p>To extract RNA, an equal volume of acid phenol:chloroform (5:1, pH 4.5; Thermo Fisher Scientific) was added to cells in resuspension buffer and mixed by vortexing. Samples were incubated at 65°C for 5 min, −80°C for 5 min, then centrifuged (15 min, 21,000 g, 4°C) to separate the aqueous and organic phases. The aqueous phase was collected and acid phenol:chloroform extraction was performed two more times on this solution. RNA transcripts were recovered by ethanol precipitation and resuspended in RNase free H<sub>2</sub>O.</p></sec><sec id="s4-7"><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: isolation of total cellular RNA from human cells</title><p>Human embryonic kidney HEK293T cells (obtained from ATCC, tested negative for mycoplasma) were maintained under 5% CO<sub>2</sub> at 37°C in DMEM medium (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (Atlanta Biologicals), 100 units/ml penicillin, and 100 µg/ml streptomycin. HEK293T cells were seeded in 100 mm tissue-culture treated plates and grown for 72 hr at 37°C or seeded in 100 mm tissue-culture treated plates, grown for 24 hr at 37°C, treated with 5 nM FK866 (Sigma Aldrich), and grown for an additional 48 hr at 37°C. Total cellular RNA was isolated with TRIzol Reagent according to the manufacture’s protocol (Thermo Fisher Scientific).</p></sec><sec id="s4-8"><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: DNAzyme cleavage</title><p>For analysis of NCIN capping of <italic>S. cerevisiae</italic> mitochondrial RNA, 40 µg of total cellular RNA was mixed with 1 µM DNAzyme (JB557 for <italic>S. cerevisiae</italic> COX2 RNA; JB526 for <italic>S. cerevisiae</italic> 21S RNA) in buffer containing 10 mM Tris pH 8.0, 50 mM NaCl, 2 mM DTT, and 10 mM MgCl<sub>2</sub> (total volume 50 µl). When present, NudC was added to 400 nM. Reactions were incubated for 60 min at 37°C and 100 µl of stop solution and 500 µl ethanol was added. Samples were centrifuged (30 min, 21,000 g, 4°C), the supernatant removed, and the pellet resuspended in RNA loading dye.</p><p>For analysis of NCIN capping of human mitochondrial RNA, 40 µg of total cellular RNA was mixed with 1 µM DNAzyme (JB559 for human LSP-generated RNA) in buffer containing 10 mM Tris pH 8.0, 50 mM NaCl, 2 mM DTT (total volume 50 µl). Samples were heated to 85°C for 5 min, cooled to 37°C. MgCl<sub>2</sub> was added to a final concentration of 10 mM and, when present, NudC was added to 400 nM. Reactions were incubated for 60 min at 37°C and 100 µl of stop solution and 500 µl ethanol was added. Samples were centrifuged (30 min, 21,000 g, 4°C), the supernatant removed, and the pellet resuspended in RNA loading dye.</p><p>To prepare synthetic RNA standards non-radiolabeled full-length RNA products were generated by in vitro transcription reactions containing 1 µM of template DNA, 1 µM of mtRNAP, 1 µM transcription factor(s), 1 mM initiating nucleotide (ATP, NAD<sup>+</sup> or NADH), 200 µM GTP, 200 µM UTP, 200 µM CTP, and 20 µM ATP. Reactions were incubated for 60 min at 25°C, stopped by addition of stop solution, extracted with acid phenol:chloroform (5:1, pH 4.5; Thermo Fisher Scientific) and ethanol precipitated. Full-length RNAs were resuspended in buffer containing 10 mM Tris pH 8.0, 50 mM NaCl, 2 mM DTT, and 10 mM MgCl<sub>2</sub> and treated with DNAzyme as described above.</p></sec><sec id="s4-9"><title>Detection and quantitation of NAD<sup>+</sup>- and NADH-capped mitochondrial RNA in vivo: hybridization with a radiolabeled oligodeoxyribonucleotide probe</title><p>NCIN capping of DNAzyme-generated subfragments of mitochondrial RNA were analyzed by a procedure consisting of: (i) electrophoresis on 7.5 M urea, 1x TBE, 10% polyacrylamide gels supplemented with 0.2% 3-acrylamidophenylboronic acid (Boron Molecular); (ii) transfer of nucleic acids to a Nytran supercharge nylon membrane (GE Healthcare Life Sciences) using a semidry transfer apparatus (Bio-Rad); (iii) immobilization of nucleic acids by UV crosslinking; (iv) incubation with a <sup>32</sup>P-labelled oligodeoxyribonucleotide probe complementary to the 5'-end containing subfragments of target RNAs (JB555, COX2 RNA; JB525, 21S RNA; JB515, LSP-derived RNA; <sup>32</sup>P-labelled using T4 polynucleotide kinase and [γ<sup>32</sup>P]-ATP [Perkin Elmer]); (v) high-stringency washing, procedures as in (<xref ref-type="bibr" rid="bib26">Goldman et al., 2015</xref>); and (vi) storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).</p><p>Bands corresponding to uncapped and NCIN-capped DNAzyme-generated subfragments were quantified using ImageQuant software. The percentages of uncapped RNA (5'-ppp), NAD<sup>+</sup>-capped RNA (5'-NAD<sup>+</sup>), or NADH-capped RNA (5'-NADH) to total RNA were determined from three biological replicates.</p></sec><sec id="s4-10"><title>Determination of NAD(H) levels in human HEK293T cells</title><p>Cells were lysed in 400 μl of NAD/H Extraction Buffer (NAD/H Quantitation Kit, Sigma-Aldrich) and total proteins were extracted with two freeze-thaw cycles (20 min on dry ice, 10 min at RT). Lysates were centrifuged (10 min, 13,000 g, 4°C), the supernatant was isolated, and the protein concentration was determined. NAD(H) was measured using a NAD/H Quantitation Kit (Sigma) from a volume of supernatant containing 10 μg protein.</p><p>Molecules of NAD(H) per cell were calculated using a value of 300 pg total protein per cell. The cellular concentration of NAD(H) was then estimated by using a cellular volume of ~1200 µm<sup>3</sup> for HEK293T cells and assuming a homogenous distribution of NAD(H) in the cell. The volume of HEK293T cells was calculated using a value of 13 µm for the diameter of HEK293T cells, assuming trypsinized cells adopt a spherical shape. NAD/H concentrations were determined from three biological replicates.</p></sec></sec></body><back><sec id="s6" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Funding acquisition, Investigation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con8"><p>Supervision, Funding acquisition, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Funding acquisition, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Writing—original draft, Project administration</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Writing—original draft, Project administration</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.42179.020</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-42179-transrepform-v3.docx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript.</p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artsimovitch</surname> <given-names>I</given-names></name><name><surname>Svetlov</surname> <given-names>V</given-names></name><name><surname>Murakami</surname> <given-names>KS</given-names></name><name><surname>Landick</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Co-overexpression of <italic>Escherichia coli</italic> RNA polymerase subunits allows isolation and analysis of mutant enzymes lacking lineage-specific sequence insertions</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>12344</fpage><lpage>12355</lpage><pub-id pub-id-type="doi">10.1074/jbc.M211214200</pub-id><pub-id pub-id-type="pmid">12511572</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname> <given-names>CO</given-names></name><name><surname>Calero</surname> <given-names>M</given-names></name><name><surname>Malik</surname> <given-names>I</given-names></name><name><surname>Graham</surname> <given-names>BW</given-names></name><name><surname>Spahr</surname> <given-names>H</given-names></name><name><surname>Lin</surname> <given-names>G</given-names></name><name><surname>Cohen</surname> <given-names>AE</given-names></name><name><surname>Brown</surname> <given-names>IS</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Pullara</surname> <given-names>F</given-names></name><name><surname>Trakselis</surname> <given-names>MA</given-names></name><name><surname>Kaplan</surname> <given-names>CD</given-names></name><name><surname>Calero</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Crystal structure of a transcribing RNA polymerase II complex reveals a complete transcription bubble</article-title><source>Molecular Cell</source><volume>59</volume><fpage>258</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.06.034</pub-id><pub-id pub-id-type="pmid">26186291</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barvík</surname> <given-names>I</given-names></name><name><surname>Rejman</surname> <given-names>D</given-names></name><name><surname>Panova</surname> <given-names>N</given-names></name><name><surname>Šanderová</surname> <given-names>H</given-names></name><name><surname>Krásný</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Non-canonical transcription initiation: the expanding universe of transcription initiating substrates</article-title><source>FEMS Microbiology Reviews</source><volume>41</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuw041</pub-id><pub-id pub-id-type="pmid">27799279</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekers</surname> <given-names>KM</given-names></name><name><surname>Heijnen</surname> <given-names>JJ</given-names></name><name><surname>van Gulik</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Determination of the in vivo NAD:NADH ratio in Saccharomyces cerevisiae under anaerobic conditions, using alcohol dehydrogenase as sensor reaction</article-title><source>Yeast</source><volume>32</volume><fpage>541</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1002/yea.3078</pub-id><pub-id pub-id-type="pmid">26059529</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname> <given-names>JG</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Tian</surname> <given-names>Y</given-names></name><name><surname>Panova</surname> <given-names>N</given-names></name><name><surname>Barvík</surname> <given-names>I</given-names></name><name><surname>Greene</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Buckley</surname> <given-names>B</given-names></name><name><surname>Krásný</surname> <given-names>L</given-names></name><name><surname>Lee</surname> <given-names>JK</given-names></name><name><surname>Kaplan</surname> <given-names>CD</given-names></name><name><surname>Ebright</surname> <given-names>RH</given-names></name><name><surname>Nickels</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The mechanism of RNA 5′ capping with NAD<sup>+</sup>, NADH and desphospho-CoA</article-title><source>Nature</source><volume>535</volume><fpage>444</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1038/nature18622</pub-id><pub-id pub-id-type="pmid">27383794</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname> <given-names>JG</given-names></name><name><surname>Nickels</surname> <given-names>BE</given-names></name><name><surname>Ebright</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RNA capping by transcription initiation with Non-canonical Initiating Nucleotides (NCINs): Determination of relative efficiencies of transcription initiation with NCINs and NTPs</article-title><source>Bio-Protocol</source><volume>7</volume><pub-id pub-id-type="doi">10.21769/BioProtoc.2336</pub-id><pub-id pub-id-type="pmid">28840175</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname> <given-names>TK</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Nucleotide sequences surrounding the nonanucleotide promoter motif influence the activity of yeast mitochondrial promoter</article-title><source>Biochemistry</source><volume>38</volume><fpage>9693</fpage><lpage>9703</lpage><pub-id pub-id-type="doi">10.1021/bi982804l</pub-id><pub-id pub-id-type="pmid">10423248</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahová</surname> <given-names>H</given-names></name><name><surname>Winz</surname> <given-names>ML</given-names></name><name><surname>Höfer</surname> <given-names>K</given-names></name><name><surname>Nübel</surname> <given-names>G</given-names></name><name><surname>Jäschke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NAD captureSeq indicates NAD as a bacterial cap for a subset of regulatory RNAs</article-title><source>Nature</source><volume>519</volume><fpage>374</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1038/nature14020</pub-id><pub-id pub-id-type="pmid">25533955</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cambronne</surname> <given-names>XA</given-names></name><name><surname>Stewart</surname> <given-names>ML</given-names></name><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Jones-Brunette</surname> <given-names>AM</given-names></name><name><surname>Morgan</surname> <given-names>RK</given-names></name><name><surname>Farrens</surname> <given-names>DL</given-names></name><name><surname>Cohen</surname> <given-names>MS</given-names></name><name><surname>Goodman</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Biosensor reveals multiple sources for mitochondrial NAD⁺</article-title><source>Science</source><volume>352</volume><fpage>1474</fpage><lpage>1477</lpage><pub-id pub-id-type="doi">10.1126/science.aad5168</pub-id><pub-id pub-id-type="pmid">27313049</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canelas</surname> <given-names>AB</given-names></name><name><surname>van Gulik</surname> <given-names>WM</given-names></name><name><surname>Heijnen</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Determination of the cytosolic free NAD/NADH ratio in <italic>Saccharomyces cerevisiae</italic> under steady-state and highly dynamic conditions</article-title><source>Biotechnology and Bioengineering</source><volume>100</volume><fpage>734</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1002/bit.21813</pub-id><pub-id pub-id-type="pmid">18383140</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cermakian</surname> <given-names>N</given-names></name><name><surname>Ikeda</surname> <given-names>TM</given-names></name><name><surname>Cedergren</surname> <given-names>R</given-names></name><name><surname>Gray</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Sequences homologous to yeast mitochondrial and bacteriophage T3 and T7 RNA polymerases are widespread throughout the eukaryotic lineage</article-title><source>Nucleic Acids Research</source><volume>24</volume><fpage>648</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1093/nar/24.4.648</pub-id><pub-id pub-id-type="pmid">8604305</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>DD</given-names></name><name><surname>Clayton</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Precise identification of individual promoters for transcription of each strand of human mitochondrial DNA</article-title><source>Cell</source><volume>36</volume><fpage>635</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(84)90343-X</pub-id><pub-id pub-id-type="pmid">6697390</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheetham</surname> <given-names>GM</given-names></name><name><surname>Steitz</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Insights into transcription: structure and function of single-subunit DNA-dependent RNA polymerases</article-title><source>Current Opinion in Structural Biology</source><volume>10</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(99)00058-5</pub-id><pub-id pub-id-type="pmid">10679468</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>YG</given-names></name><name><surname>Kowtoniuk</surname> <given-names>WE</given-names></name><name><surname>Agarwal</surname> <given-names>I</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>LC/MS analysis of cellular RNA reveals NAD-linked RNA</article-title><source>Nature Chemical Biology</source><volume>5</volume><fpage>879</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1038/nchembio.235</pub-id><pub-id pub-id-type="pmid">19820715</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>RA</given-names></name><name><surname>Down</surname> <given-names>TA</given-names></name><name><surname>Stempor</surname> <given-names>P</given-names></name><name><surname>Chen</surname> <given-names>QB</given-names></name><name><surname>Egelhofer</surname> <given-names>TA</given-names></name><name><surname>Hillier</surname> <given-names>LW</given-names></name><name><surname>Jeffers</surname> <given-names>TE</given-names></name><name><surname>Ahringer</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The landscape of RNA polymerase II transcription initiation in C. elegans reveals promoter and enhancer architectures</article-title><source>Genome Research</source><volume>23</volume><fpage>1339</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1101/gr.153668.112</pub-id><pub-id pub-id-type="pmid">23550086</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>WW</given-names></name><name><surname>Freinkman</surname> <given-names>E</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Birsoy</surname> <given-names>K</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Absolute quantification of matrix metabolites reveals the dynamics of mitochondrial metabolism</article-title><source>Cell</source><volume>166</volume><fpage>1324</fpage><lpage>1337</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.040</pub-id><pub-id pub-id-type="pmid">27565352</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Multisubunit RNA polymerases</article-title><source>Current Opinion in Structural Biology</source><volume>12</volume><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(02)00294-4</pub-id><pub-id pub-id-type="pmid">11839495</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darst</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Bacterial RNA polymerase</article-title><source>Current Opinion in Structural Biology</source><volume>11</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(00)00185-8</pub-id><pub-id pub-id-type="pmid">11297923</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deana</surname> <given-names>A</given-names></name><name><surname>Celesnik</surname> <given-names>H</given-names></name><name><surname>Belasco</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The bacterial enzyme RppH triggers messenger RNA degradation by 5' pyrophosphate removal</article-title><source>Nature</source><volume>451</volume><fpage>355</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1038/nature06475</pub-id><pub-id pub-id-type="pmid">18202662</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dedrick</surname> <given-names>RL</given-names></name><name><surname>Chamberlin</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Studies on transcription of 3'-extended templates by mammalian RNA polymerase II. Parameters that affect the initiation and elongation reactions</article-title><source>Biochemistry</source><volume>24</volume><fpage>2245</fpage><lpage>2253</lpage><pub-id pub-id-type="doi">10.1021/bi00330a019</pub-id><pub-id pub-id-type="pmid">2581610</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname> <given-names>AP</given-names></name><name><surname>Patel</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interactions of the yeast mitochondrial RNA polymerase with the +1 and +2 promoter bases dictate transcription initiation efficiency</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>11721</fpage><lpage>11732</lpage><pub-id pub-id-type="doi">10.1093/nar/gku868</pub-id><pub-id pub-id-type="pmid">25249624</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebright</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>RNA polymerase: structural similarities between bacterial RNA polymerase and eukaryotic RNA polymerase II</article-title><source>Journal of Molecular Biology</source><volume>304</volume><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1006/jmbi.2000.4309</pub-id><pub-id pub-id-type="pmid">11124018</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frindert</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Nübel</surname> <given-names>G</given-names></name><name><surname>Kahloon</surname> <given-names>M</given-names></name><name><surname>Kolmar</surname> <given-names>L</given-names></name><name><surname>Hotz-Wagenblatt</surname> <given-names>A</given-names></name><name><surname>Burhenne</surname> <given-names>J</given-names></name><name><surname>Haefeli</surname> <given-names>WE</given-names></name><name><surname>Jäschke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Identification, biosynthesis, and decapping of NAD-Capped RNAs in <italic>B. subtilis</italic></article-title><source>Cell Reports</source><volume>24</volume><fpage>1890</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.047</pub-id><pub-id pub-id-type="pmid">30110644</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuichi</surname> <given-names>Y</given-names></name><name><surname>Shatkin</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Viral and cellular mRNA capping: past and prospects</article-title><source>Advances in Virus Research</source><volume>55</volume><fpage>135</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/S0065-3527(00)55003-9</pub-id><pub-id pub-id-type="pmid">11050942</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>A</given-names></name><name><surname>Lima</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Enzymology of RNA cap synthesis</article-title><source>Wiley Interdisciplinary Reviews: RNA</source><volume>1</volume><fpage>152</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1002/wrna.19</pub-id><pub-id pub-id-type="pmid">21956912</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname> <given-names>SR</given-names></name><name><surname>Nair</surname> <given-names>NU</given-names></name><name><surname>Wells</surname> <given-names>CD</given-names></name><name><surname>Nickels</surname> <given-names>BE</given-names></name><name><surname>Hochschild</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The primary σ factor in <italic>Escherichia coli</italic> can access the transcription elongation complex from solution <italic>in vivo</italic></article-title><source>eLife</source><volume>4</volume><elocation-id>e10514</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.10514</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haberle</surname> <given-names>V</given-names></name><name><surname>Li</surname> <given-names>N</given-names></name><name><surname>Hadzhiev</surname> <given-names>Y</given-names></name><name><surname>Plessy</surname> <given-names>C</given-names></name><name><surname>Previti</surname> <given-names>C</given-names></name><name><surname>Nepal</surname> <given-names>C</given-names></name><name><surname>Gehrig</surname> <given-names>J</given-names></name><name><surname>Dong</surname> <given-names>X</given-names></name><name><surname>Akalin</surname> <given-names>A</given-names></name><name><surname>Suzuki</surname> <given-names>AM</given-names></name><name><surname>van IJcken</surname> <given-names>WFJ</given-names></name><name><surname>Armant</surname> <given-names>O</given-names></name><name><surname>Ferg</surname> <given-names>M</given-names></name><name><surname>Strähle</surname> <given-names>U</given-names></name><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Müller</surname> <given-names>F</given-names></name><name><surname>Lenhard</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Two independent transcription initiation codes overlap on vertebrate core promoters</article-title><source>Nature</source><volume>507</volume><fpage>381</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1038/nature12974</pub-id><pub-id pub-id-type="pmid">24531765</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasmann</surname> <given-names>M</given-names></name><name><surname>Schemainda</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis</article-title><source>Cancer Research</source><volume>63</volume><fpage>7436</fpage><lpage>7442</lpage><pub-id pub-id-type="pmid">14612543</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillen</surname> <given-names>HS</given-names></name><name><surname>Temiakov</surname> <given-names>D</given-names></name><name><surname>Cramer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structural basis of mitochondrial transcription</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>25</volume><fpage>754</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1038/s41594-018-0122-9</pub-id><pub-id pub-id-type="pmid">30190598</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höfer</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Abele</surname> <given-names>F</given-names></name><name><surname>Frindert</surname> <given-names>J</given-names></name><name><surname>Schlotthauer</surname> <given-names>J</given-names></name><name><surname>Grawenhoff</surname> <given-names>J</given-names></name><name><surname>Du</surname> <given-names>J</given-names></name><name><surname>Patel</surname> <given-names>DJ</given-names></name><name><surname>Jäschke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structure and function of the bacterial decapping enzyme NudC</article-title><source>Nature Chemical Biology</source><volume>12</volume><fpage>730</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2132</pub-id><pub-id pub-id-type="pmid">27428510</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höfer</surname> <given-names>K</given-names></name><name><surname>Jäschke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Epitranscriptomics: RNA modifications in bacteria and archaea</article-title><source>Microbiology Spectrum</source><volume>6</volume><pub-id pub-id-type="doi">10.1128/microbiolspec.RWR-0015-2017</pub-id><pub-id pub-id-type="pmid">29916347</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igloi</surname> <given-names>GL</given-names></name><name><surname>Kössel</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Affinity electrophoresis for monitoring terminal phosphorylation and the presence of queuosine in RNA. Application of polyacrylamide containing a covalently bound boronic acid</article-title><source>Nucleic Acids Research</source><volume>13</volume><fpage>6881</fpage><lpage>6898</lpage><pub-id pub-id-type="doi">10.1093/nar/13.19.6881</pub-id><pub-id pub-id-type="pmid">2414733</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igloi</surname> <given-names>GL</given-names></name><name><surname>Kössel</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Use of boronate-containing gels for electrophoretic analysis of both ends of RNA molecules</article-title><source>Methods in Enzymology</source><volume>155</volume><fpage>433</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">2448586</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jäschke</surname> <given-names>A</given-names></name><name><surname>Höfer</surname> <given-names>K</given-names></name><name><surname>Nübel</surname> <given-names>G</given-names></name><name><surname>Frindert</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cap-like structures in bacterial RNA and epitranscriptomic modification</article-title><source>Current Opinion in Microbiology</source><volume>30</volume><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2015.12.009</pub-id><pub-id pub-id-type="pmid">26779928</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>Y</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Patel</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Equilibrium and stopped-flow kinetic studies of interaction between T7 RNA polymerase and its promoters measured by protein and 2-aminopurine fluorescence changes</article-title><source>Journal of Biological Chemistry</source><volume>271</volume><fpage>30451</fpage><lpage>30458</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.48.30451</pub-id><pub-id pub-id-type="pmid">8940010</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname> <given-names>X</given-names></name><name><surname>Doamekpor</surname> <given-names>SK</given-names></name><name><surname>Bird</surname> <given-names>JG</given-names></name><name><surname>Nickels</surname> <given-names>BE</given-names></name><name><surname>Tong</surname> <given-names>L</given-names></name><name><surname>Hart</surname> <given-names>RP</given-names></name><name><surname>Kiledjian</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>5' End nicotinamide adenine dinucleotide cap in human cells promotes RNA decay through DXO-Mediated deNADding</article-title><source>Cell</source><volume>168</volume><fpage>1015</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.02.019</pub-id><pub-id pub-id-type="pmid">28283058</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname> <given-names>GF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>RNA cleavage by the 10-23 DNA enzyme</article-title><source>Methods in Enzymology</source><volume>341</volume><fpage>503</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">11582801</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julius</surname> <given-names>C</given-names></name><name><surname>Riaz-Bradley</surname> <given-names>A</given-names></name><name><surname>Yuzenkova</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA capping by mitochondrial and multi-subunit RNA polymerases</article-title><source>Transcription</source><volume>9</volume><fpage>292</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1080/21541264.2018.1456258</pub-id><pub-id pub-id-type="pmid">29624107</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julius</surname> <given-names>C</given-names></name><name><surname>Yuzenkova</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Bacterial RNA polymerase caps RNA with various cofactors and cell wall precursors</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>8282</fpage><lpage>8290</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx452</pub-id><pub-id pub-id-type="pmid">28531287</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadesch</surname> <given-names>TR</given-names></name><name><surname>Chamberlin</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Studies of in vitro transcription by calf thymus RNA polymerase II using a novel duplex DNA template</article-title><source>The Journal of Biological Chemistry</source><volume>257</volume><fpage>5286</fpage><lpage>5295</lpage><pub-id pub-id-type="pmid">7068686</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>JA</given-names></name><name><surname>Tao</surname> <given-names>X</given-names></name><name><surname>Tong</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>13</volume><fpage>582</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1038/nsmb1105</pub-id><pub-id pub-id-type="pmid">16783377</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Rucobo</surname> <given-names>FW</given-names></name><name><surname>Kohler</surname> <given-names>R</given-names></name><name><surname>van de Waterbeemd</surname> <given-names>M</given-names></name><name><surname>Heck</surname> <given-names>AJR</given-names></name><name><surname>Hemann</surname> <given-names>M</given-names></name><name><surname>Herzog</surname> <given-names>F</given-names></name><name><surname>Stark</surname> <given-names>H</given-names></name><name><surname>Cramer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular basis of transcription-coupled Pre-mRNA capping</article-title><source>Molecular Cell</source><volume>58</volume><fpage>1079</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.04.004</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masters</surname> <given-names>BS</given-names></name><name><surname>Stohl</surname> <given-names>LL</given-names></name><name><surname>Clayton</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Yeast mitochondrial RNA polymerase is homologous to those encoded by bacteriophages T3 and T7</article-title><source>Cell</source><volume>51</volume><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(87)90013-4</pub-id><pub-id pub-id-type="pmid">3308116</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAllister</surname> <given-names>WT</given-names></name><name><surname>Raskin</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The phage RNA polymerases are related to DNA polymerases and reverse transcriptases</article-title><source>Molecular Microbiology</source><volume>10</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.1993.tb00897.x</pub-id><pub-id pub-id-type="pmid">7526118</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nübel</surname> <given-names>G</given-names></name><name><surname>Sorgenfrei</surname> <given-names>FA</given-names></name><name><surname>Jäschke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Boronate affinity electrophoresis for the purification and analysis of cofactor-modified RNAs</article-title><source>Methods</source><volume>117</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2016.09.008</pub-id><pub-id pub-id-type="pmid">27645507</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paratkar</surname> <given-names>S</given-names></name><name><surname>Patel</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mitochondrial transcription factor Mtf1 traps the unwound non-template strand to facilitate open complex formation</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>3949</fpage><lpage>3956</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.050732</pub-id><pub-id pub-id-type="pmid">20008320</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>JO</given-names></name><name><surname>Rubin</surname> <given-names>SA</given-names></name><name><surname>Xu</surname> <given-names>YF</given-names></name><name><surname>Amador-Noguez</surname> <given-names>D</given-names></name><name><surname>Fan</surname> <given-names>J</given-names></name><name><surname>Shlomi</surname> <given-names>T</given-names></name><name><surname>Rabinowitz</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolite concentrations, fluxes and free energies imply efficient enzyme usage</article-title><source>Nature Chemical Biology</source><volume>12</volume><fpage>482</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2077</pub-id><pub-id pub-id-type="pmid">27159581</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname> <given-names>A</given-names></name><name><surname>Basu</surname> <given-names>U</given-names></name><name><surname>Sultana</surname> <given-names>S</given-names></name><name><surname>Nandakumar</surname> <given-names>D</given-names></name><name><surname>Patel</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human mitochondrial transcription factors TFAM and TFB2M work synergistically in promoter melting during transcription initiation</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>861</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1157</pub-id><pub-id pub-id-type="pmid">27903899</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanathan</surname> <given-names>A</given-names></name><name><surname>Robb</surname> <given-names>GB</given-names></name><name><surname>Chan</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>mRNA capping: biological functions and applications</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>7511</fpage><lpage>7526</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw551</pub-id><pub-id pub-id-type="pmid">27317694</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ringel</surname> <given-names>R</given-names></name><name><surname>Sologub</surname> <given-names>M</given-names></name><name><surname>Morozov</surname> <given-names>YI</given-names></name><name><surname>Litonin</surname> <given-names>D</given-names></name><name><surname>Cramer</surname> <given-names>P</given-names></name><name><surname>Temiakov</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structure of human mitochondrial RNA polymerase</article-title><source>Nature</source><volume>478</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/nature10435</pub-id><pub-id pub-id-type="pmid">21947009</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname> <given-names>TL</given-names></name><name><surname>Hashimoto</surname> <given-names>S</given-names></name><name><surname>Gu</surname> <given-names>SG</given-names></name><name><surname>Morton</surname> <given-names>JJ</given-names></name><name><surname>Stadler</surname> <given-names>M</given-names></name><name><surname>Blumenthal</surname> <given-names>T</given-names></name><name><surname>Fire</surname> <given-names>A</given-names></name><name><surname>Morishita</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The transcription start site landscape of <italic>C. elegans</italic></article-title><source>Genome Research</source><volume>23</volume><fpage>1348</fpage><lpage>1361</lpage><pub-id pub-id-type="doi">10.1101/gr.151571.112</pub-id><pub-id pub-id-type="pmid">23636945</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shatkin</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Capping of eucaryotic mRNAs</article-title><source>Cell</source><volume>9</volume><fpage>645</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(76)90128-8</pub-id><pub-id pub-id-type="pmid">1017010</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuman</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Capping enzyme in eukaryotic mRNA synthesis</article-title><source>Progress in Nucleic Acid Research and Molecular Biology</source><volume>50</volume><fpage>101</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">7754031</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuman</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Structure, mechanism, and evolution of the mRNA capping apparatus</article-title><source>Progress in Nucleic Acid Research and Molecular Biology</source><volume>66</volume><fpage>1</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">11051760</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuman</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RNA capping: progress and prospects</article-title><source>RNA</source><volume>21</volume><fpage>735</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1261/rna.049973.115</pub-id><pub-id pub-id-type="pmid">25780214</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sologub</surname> <given-names>M</given-names></name><name><surname>Litonin</surname> <given-names>D</given-names></name><name><surname>Anikin</surname> <given-names>M</given-names></name><name><surname>Mustaev</surname> <given-names>A</given-names></name><name><surname>Temiakov</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TFB2 is a transient component of the catalytic site of the human mitochondrial RNA polymerase</article-title><source>Cell</source><volume>139</volume><fpage>934</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.10.031</pub-id><pub-id pub-id-type="pmid">19945377</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Structural and mechanistic relationships between nucleic acid polymerases</article-title><source>Trends in Biochemical Sciences</source><volume>21</volume><fpage>186</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(96)10023-2</pub-id><pub-id pub-id-type="pmid">8871404</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taanman</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The mitochondrial genome: structure, transcription, translation and replication</article-title><source>Biochimica et Biophysica Acta (BBA) - Bioenergetics</source><volume>1410</volume><fpage>103</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/S0005-2728(98)00161-3</pub-id><pub-id pub-id-type="pmid">10076021</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>GQ</given-names></name><name><surname>Paratkar</surname> <given-names>S</given-names></name><name><surname>Patel</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fluorescence mapping of the open complex of yeast mitochondrial RNA polymerase</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>5514</fpage><lpage>5522</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807880200</pub-id><pub-id pub-id-type="pmid">19116203</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatchell</surname> <given-names>K</given-names></name><name><surname>Nasmyth</surname> <given-names>KA</given-names></name><name><surname>Hall</surname> <given-names>BD</given-names></name><name><surname>Astell</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title><italic>In vitro</italic> mutation analysis of the mating-type locus in yeast</article-title><source>Cell</source><volume>27</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(81)90357-3</pub-id><pub-id pub-id-type="pmid">6276023</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomason</surname> <given-names>MK</given-names></name><name><surname>Bischler</surname> <given-names>T</given-names></name><name><surname>Eisenbart</surname> <given-names>SK</given-names></name><name><surname>Förstner</surname> <given-names>KU</given-names></name><name><surname>Zhang</surname> <given-names>A</given-names></name><name><surname>Herbig</surname> <given-names>A</given-names></name><name><surname>Nieselt</surname> <given-names>K</given-names></name><name><surname>Sharma</surname> <given-names>CM</given-names></name><name><surname>Storz</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Global transcriptional start site mapping using differential RNA sequencing reveals novel antisense RNAs in <italic>Escherichia coli</italic></article-title><source>Journal of Bacteriology</source><volume>197</volume><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1128/JB.02096-14</pub-id><pub-id pub-id-type="pmid">25266388</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchihara</surname> <given-names>K</given-names></name><name><surname>Suzuki</surname> <given-names>Y</given-names></name><name><surname>Wakaguri</surname> <given-names>H</given-names></name><name><surname>Irie</surname> <given-names>T</given-names></name><name><surname>Tanimoto</surname> <given-names>K</given-names></name><name><surname>Hashimoto</surname> <given-names>S</given-names></name><name><surname>Matsushima</surname> <given-names>K</given-names></name><name><surname>Mizushima-Sugano</surname> <given-names>J</given-names></name><name><surname>Yamashita</surname> <given-names>R</given-names></name><name><surname>Nakai</surname> <given-names>K</given-names></name><name><surname>Bentley</surname> <given-names>D</given-names></name><name><surname>Esumi</surname> <given-names>H</given-names></name><name><surname>Sugano</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Massive transcriptional start site analysis of human genes in hypoxia cells</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>2249</fpage><lpage>2263</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp066</pub-id><pub-id pub-id-type="pmid">19237398</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasilyev</surname> <given-names>N</given-names></name><name><surname>Gao</surname> <given-names>A</given-names></name><name><surname>Serganov</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Noncanonical features and modifications on the 5'-end of bacterial sRNAs and mRNAs</article-title><source>Wiley Interdisciplinary Reviews: RNA</source><elocation-id>e1509</elocation-id><pub-id pub-id-type="doi">10.1002/wrna.1509</pub-id><pub-id pub-id-type="pmid">30276982</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vvedenskaya</surname> <given-names>IO</given-names></name><name><surname>Bird</surname> <given-names>JG</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Jiao</surname> <given-names>X</given-names></name><name><surname>Barvík</surname> <given-names>I</given-names></name><name><surname>Krásný</surname> <given-names>L</given-names></name><name><surname>Kiledjian</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>DM</given-names></name><name><surname>Ebright</surname> <given-names>RH</given-names></name><name><surname>Nickels</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CapZyme-Seq comprehensively defines promoter-sequence determinants for RNA 5' capping with NAD</article-title><source>Molecular Cell</source><volume>70</volume><fpage>553</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.03.014</pub-id><pub-id pub-id-type="pmid">29681497</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walters</surname> <given-names>RW</given-names></name><name><surname>Matheny</surname> <given-names>T</given-names></name><name><surname>Mizoue</surname> <given-names>LS</given-names></name><name><surname>Rao</surname> <given-names>BS</given-names></name><name><surname>Muhlrad</surname> <given-names>D</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Identification of NAD<sup>+</sup> capped mRNAs in <italic>Saccharomyces cerevisiae</italic></article-title><source>PNAS</source><volume>114</volume><fpage>480</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1073/pnas.1619369114</pub-id><pub-id pub-id-type="pmid">28031484</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>CM</given-names></name><name><surname>Gershowitz</surname> <given-names>A</given-names></name><name><surname>Moss</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Methylated nucleotides block 5' terminus of HeLa cell messenger RNA</article-title><source>Cell</source><volume>4</volume><fpage>379</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(75)90158-0</pub-id><pub-id pub-id-type="pmid">164293</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname> <given-names>F</given-names></name><name><surname>Grohmann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Evolution of multisubunit RNA polymerases in the three domains of life</article-title><source>Nature Reviews Microbiology</source><volume>9</volume><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2507</pub-id><pub-id pub-id-type="pmid">21233849</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winz</surname> <given-names>ML</given-names></name><name><surname>Cahová</surname> <given-names>H</given-names></name><name><surname>Nübel</surname> <given-names>G</given-names></name><name><surname>Frindert</surname> <given-names>J</given-names></name><name><surname>Höfer</surname> <given-names>K</given-names></name><name><surname>Jäschke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Capture and sequencing of NAD-capped RNA sequences with NAD captureSeq</article-title><source>Nature Protocols</source><volume>12</volume><fpage>122</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.163</pub-id><pub-id pub-id-type="pmid">27977022</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakubovskaya</surname> <given-names>E</given-names></name><name><surname>Guja</surname> <given-names>KE</given-names></name><name><surname>Eng</surname> <given-names>ET</given-names></name><name><surname>Choi</surname> <given-names>WS</given-names></name><name><surname>Mejia</surname> <given-names>E</given-names></name><name><surname>Beglov</surname> <given-names>D</given-names></name><name><surname>Lukin</surname> <given-names>M</given-names></name><name><surname>Kozakov</surname> <given-names>D</given-names></name><name><surname>Garcia-Diaz</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Organization of the human mitochondrial transcription initiation complex</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>4100</fpage><lpage>4112</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1360</pub-id><pub-id pub-id-type="pmid">24413562</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.42179.022</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Hinnebusch</surname><given-names>Alan G</given-names></name><role>Reviewing Editor</role><aff><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Highly efficient 5' capping of mitochondrial RNA with NAD+ and NADH by yeast and human mitochondrial RNA polymerase&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by James Manley as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Ann Hochschild (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>This paper uses a combination of in-depth biochemical analysis and a novel in vivo approach to provide important new insights into NAD/NADH capping of eukaryotic mitochondrial transcripts and of this capping process in general. Using purified RNA polymerases from yeast or human mitochondria (mt), as well yeast nuclear, <italic>E. coli</italic> and T7 RNA Pol enzymes, they show by careful enzyme kinetics that the mt enzymes are considerably more efficient than the yeast and <italic>E. coli</italic> enzymes at NAD+ capping in vitro. They further show that the mt enzymes and T7 Pol, all single polypeptide polymerases, exhibit the same promoter sequence specificity for the reaction demonstrated previously for the <italic>E. coli</italic> multi-subunit enzyme, requiring a T on the template strand for the TSS (+1 position) and a purine:pyrimidine base pair on the non-template:template strands at the -1 position. They introduce a significant advance in the techniques for quantifying the occurrence of NAD+ and NADH, vs uncapped mt transcripts produced in vivo, and show that the proportions of NAD+/NADH vs. uncapped transcripts for two yeast and one human mt transcripts are much higher than observed previously for bacterial transcripts and yeast cytoplasmic mRNAs. Finally, they show that the ratio of NAD+ vs NADH capped mRNAs for the two yeast mt mRNAs vary in response to altered growth conditions expected to change the NAD+/NADH ratio in cells, providing evidence that mt RNAP could be utilized as a sensor of energy metabolism that would generate altered ratios of NAD+ vs NADH-capped mt mRNAs. In view of their findings that a large fraction of the mt transcripts harbor one or the other cap, this has the potential of altering mt gene expression through possible influences of these caps on mRNA translation or turnover.</p><p>Although NAD+ capped yeast mt mRNAs had been detected previously, this work is significant in providing direct evidence that mt RNAPs carry out this reaction and utilize the same promoter sequences found for multi-subunit RNAPs to direct capping; and they also function much more efficiently than do the latter. The results also provide evidence that the capped mt transcripts detected in cells represent capping during transcription initiation vs. capping of degradation products. By measuring the precise proportions of NAD+-capped, NADH-capped, and uncapped mt mRNAs in cells-which is much higher than seen previously for bacterial or yeast cytoplasmic mRNAs-they show that the ratio of NAD+ to NADH-capped mRNAs varies with the energy status of yeast cells.</p><p>Essential revisions:</p><p>It is requested that you discuss how the relative levels of NAD/NADH capping of mitochondrial versus cytoplasmic mRNAs could be affected by different concentrations of NAD/NADH in the mitochondria versus eukaryotic nuclei or <italic>E. coli</italic> cells in addition to the different capping efficiencies of the respective RNA polymerases, and cite any information available about these concentrations.</p><p>It is requested that you provide a much better explanation of how the &quot;fork-junction&quot; template works and how it bypasses the requirement for sequence-specific RNAP-DNA interactions and transcription-initiation factor-DNA interactions for transcription initiation, as neither the text nor cartoon were found to be adequate.</p><p>It is requested that you state more explicitly how the conclusion that &quot;mitochondrial RNAs undergo NAD+ capping at 5' ends generated by transcription initiation (as opposed 5' ends generated by RNA processing&quot; follows from the data provided.</p><p>It is requested that you discuss what is known about whether the capping ratio affects the amount of transcript, the stability of the transcript, or the efficiency with which it is translated.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.42179.023</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>It is requested that you discuss how the relative levels of NAD/NADH capping of mitochondrial versus cytoplasmic mRNAs could be affected by different concentrations of NAD/NADH in the mitochondria versus eukaryotic nuclei or E. coli cells in addition to the different capping efficiencies of the respective RNA polymerases, and cite any information available about these concentrations.</p></disp-quote><p>We have modified the text in the second paragraph of the Discussion to address this point. The revised text is:</p><p>“First, mtRNAPs are substantially more efficient at NAD<sup>+</sup> and NADH capping than bacterial and eukaryotic nuclear RNAPs (Figure 2C). Second, levels of NAD<sup>+</sup> and NADH relative to ATP in mitochondria are substantially higher than levels of NAD<sup>+</sup> and NADH relative to ATP in bacteria and eukaryotic nuclei (Cambronne et al., 2016; W. W. Chenet al., 2016; Parket al., 2016).”</p><disp-quote content-type="editor-comment"><p>It is requested that you provide a much better explanation of how the &quot;fork-junction&quot; template works and how it bypasses the requirement for sequence-specific RNAP-DNA interactions and transcription-initiation factor-DNA interactions for transcription initiation, as neither the text nor cartoon were found to be adequate.</p></disp-quote><p>We have revised the text to indicate that the template used for these assays is a “tailed” template and provided references establishing use of a tailed template to bypass the requirement for sequence-specific RNAP-DNA interactions and transcription-initiation factor-DNA interactions. The revised text is:</p><p>“…we performed transcription assays using a “tailed” template (Figure 2C, top) that bypasses the requirement for sequence-specific RNAP-DNA interactions and transcription-initiation factor-DNA interactions for transcription initiation (Dedrick and Chamberlin, 1985; Kadesch and Chamberlin, 1982).”</p><disp-quote content-type="editor-comment"><p>It is requested that you state more explicitly how the conclusion that &quot;mitochondrial RNAs undergo NAD+ capping at 5' ends generated by transcription initiation (as opposed 5' ends generated by RNA processing&quot; follows from the data provided.</p></disp-quote><p>We have revised the text to clarify this point by adding the following sentence to the Results section:</p><p>“Because the hybridization probe detects RNA fragments that contain 5' ends generated by transcription initiation (red sub-fragment depicted in Figure 4A), the detected NAD<sup>+</sup> and NADH caps are concluded to be at 5' ends generated by transcription initiation, as opposed to 5' ends generated by RNA processing.”</p><disp-quote content-type="editor-comment"><p>It is requested that you discuss what is known about whether the capping ratio affects the amount of transcript, the stability of the transcript, or the efficiency with which it is translated.</p></disp-quote><p>We have modified the text at the beginning of the second paragraph of the Discussion. The revised text is:</p><p>“We and others previously have shown that NCIN capping by cellular RNAPs has functional consequences, including modulating RNA stability and modulating RNA translatability.”</p></body></sub-article></article>